Antihypertensive medication - note that there are other indications

RX_ANTIHYP

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — C0[789] 1 out of 7 registries used, show all original rules.	295206
4. Check minimum number of events Min. number of events 3	295206
5. Include endpoints None	295206
6. Filter based on genotype QC (FinnGen only)	286708

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	RX_ANTIHYP
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	C0[789]
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Antihypertensive medication - note that there are other indications based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2334599	1215225	1102476
Only index persons	2040159	1081643	958516
Unadjusted period prevalence (%)
Whole population	32.79	34.81	30.80
Only index persons	38.27	39.76	36.59
Median age at first event (years)
Whole population	57.85	58.94	56.51
Only index persons	56.16	57.07	55.14

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	286708	148805	137903
Unadjusted period prevalence (%)	57.78	52.78	63.18
Median age at first event (years)	54.47	52.79	56.29

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
42077: Matched controls
223000

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N05AH02

ATC

clozapine; systemic

4.5

323.3

1009

1198

N06AA09

ATC

amitriptyline; systemic

2.6

323.0

2250

4658

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.2

321.8

1618

2767

A10AB04

ATC

insulin lispro; parenteral

3.8

320.2

1263

1822

R53

ICD-10 Finland

Malaise and fatigue

1.7

319.9

8423

28862

C03BA11

ATC

indapamide; oral

22.3

319.5

376

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

318.4

2542

5640

M01AE02

ATC

naproxen; oral, rectal

1.5

316.7

21911

93732

XCK10

NOMESCO Finland

Photography of fundus of eye

2.6

316.3

2268

4766

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

316.1

4074

11108

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.6

316.1

1322

1992

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.9

315.8

1844

3458

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

315.5

10730

39240

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.1

313.2

1630

2849

A12AA04

ATC

calcium carbonate; oral

15.6

312.8

415

142

AN4

Balloon angioplasty and drug eluding stent

22.9

311.5

364

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.0

310.4

1110

1482

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

109.4

309.9

287

I47.2

ICD-10 Finland

Ventricular tachycardia

13.8

309.6

432

167

I50.9

ICD-10 Finland

Heart failure, unspecified

9.3

307.7

2049

1227

C03DA01

ATC

spironolactone; oral

5.5

307.7

2706

2756

127

Kela drug reimbursment

Transplant complication

17.2

307.7

685

214

K86

ICPC

Hypertension uncomplicated

29.7

307.7

2577

488

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

307.7

4213

9195

C09CA06

ATC

candesartan; oral

25.0

307.7

12199

3586

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

10.3

307.7

758

395

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.9

307.7

4121

6056

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

307.7

8001

20965

E66.00

ICD-10 Finland

Metabolic syndrome

5.8

307.7

1714

1615

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

4.5

307.7

2769

3455

C07BB07

ATC

bisoprolol and thiazides; systemic

282.5

307.7

630

A02BC02

ATC

pantoprazole; systemic

2.1

307.7

24528

88492

C09CA01

ATC

losartan; oral

38.8

307.7

8347

1413

Z94.0

ICD-10 Finland

Kidney transplant status

86.5

307.7

516

M79.6

ICD-10 Finland

Pain in limb

1.6

307.7

14477

54511

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

4.3

307.7

2858

3740

N05CF01

ATC

zopiclone; oral

2.0

307.7

9981

29430

N06AB06

ATC

sertraline; oral

2.3

307.7

5213

12952

I20.99

ICD-10 Finland

Angina pectoris, unspecified

6.7

307.7

888

720

N02CD03

ATC

fremanezumab; systemic

21.9

307.7

670

165

N06AB04

ATC

citalopram; systemic

2.2

307.7

7471

20024

I25.2

ICD-10 Finland

Old myocardial infarction

17.4

307.7

914

284

J01AA02

ATC

doxycycline; systemic

1.7

307.7

27603

118449

J01DB01

ATC

cefalexin; oral

1.8

307.7

32723

147963

L04AA06

ATC

mycophenolic acid; systemic

10.6

307.7

787

400

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

40.8

307.7

756

100

A10AE05

ATC

insulin detemir; parenteral

3.7

307.7

1693

2491

N18.8

ICD-10 Finland

Other chronic renal failure

23.6

307.7

532

121

C08CA13

ATC

lercanidipine; oral

117.2

307.7

3398

167

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.6

307.7

2784

6021

N03AX09

ATC

lamotrigine; oral

3.3

307.7

2676

4462

N02CC04

ATC

rizatriptan; oral

3.1

307.7

2765

4876

C08DA01

ATC

verapamil; systemic

16.7

307.7

1147

374

C08CA01

ATC

amlodipine; oral

47.2

307.7

12121

1894

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

20.0

307.7

647

174

M54.5

ICD-10 Finland

Low back pain

1.6

307.7

13104

49352

SPAT1097

SPAT

Recording of ECG

2.6

307.7

3379

7190

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

5.0

307.7

5740

6852

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

307.7

5090

13749

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

30.2

307.7

463

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

5.9

307.7

1517

1415

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.6

307.7

2103

3206

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

307.7

2228

4265

C08DB01

ATC

diltiazem; oral

24.4

307.7

680

150

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.8

307.7

1723

2477

C09BB04

ATC

perindopril and amlodipine; systemic

91.9

307.7

344

N02BF02

ATC

pregabalin; oral

2.9

307.7

1953

3671

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

307.7

2065

3661

C10AA05

ATC

atorvastatin; oral

3.3

307.7

10267

19865

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

307.7

3041

6674

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.0

307.7

4122

7861

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

307.7

5760

16214

K78

ICPC

Atrial fibrillation/flutter

8.5

307.7

901

570

N03AX16

ATC

[U] pregabalin

2.3

307.7

7399

18909

A10BH01

ATC

sitagliptin; oral

5.3

307.7

1829

1900

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

10.0

307.7

815

439

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

6.7

307.7

1879

1543

C01DA14

ATC

isosorbide mononitrate; oral

9.4

307.7

2194

1299

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

307.7

7088

22595

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

9.6

307.7

1553

888

N05AH03

ATC

olanzapine; systemic

2.9

307.7

3032

5797

C08CA05

ATC

nifedipine; systemic

6.9

307.7

1577

1251

G43.3

ICD-10 Finland

Complicated migraine

9.7

307.7

1191

665

C02AC05

ATC

moxonidine; oral

252.6

307.7

841

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

307.7

15539

56215

XF404

NOMESCO Finland

Ambulatory ECG

4.6

307.7

2385

2849

C01BD01

ATC

amiodarone; systemic

63.0

307.7

412

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

10.1

307.7

1258

678

A10AB01

ATC

insulin (human); parenteral

3.7

307.7

1405

2088

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.7

8340

27815

C09DB01

ATC

valsartan and amlodipine; oral

54.5

307.7

758

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.5

307.7

3557

7918

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

24.8

307.7

973

213

A10BJ06

ATC

semaglutide; parenteral

9.5

307.7

1469

844

TFP34

NOMESCO Finland

Electrophysiological investigation

6.3

307.7

853

733

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.7

307.7

3689

4473

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

33.9

307.7

649

103

WX872

NOMESCO Finland

Intensive care

4.7

307.7

1097

1254

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

8.8

307.7

680

416

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

134.8

307.7

328

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

56.7

307.7

653

C03CA01

ATC

furosemide; systemic

4.9

307.7

6282

7668

C09AA04

ATC

perindopril; oral

43.1

307.7

1017

128

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

8.6

307.7

594

372

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

307.7

5954

17715

C01AA05

ATC

digoxin; systemic

5.7

307.7

1089

1030

I20.09

ICD-10 Finland

Unstable angina

8.6

307.7

790

495

SPAT1262

SPAT

Handing over of treatment supplies

2.9

307.7

4770

9375

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

21.0

307.7

423

108

I48.2

ICD-10 Finland

Chronic atrial fibrillation

22.9

307.7

399

A10BB12

ATC

glimepiride; oral

5.8

307.7

889

828

N06AX16

ATC

venlafaxine; oral

2.6

307.7

6742

15241

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

9.9

307.7

1686

938

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.4

307.7

1637

2598

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

9.0

307.7

910

547

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.8

307.7

4159

8480

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.4

307.7

6369

11191

C07AA05

ATC

propranolol; systemic

6.1

307.7

12895

15080

3007

Kela drug reimbursment

Erenumab and fremanezumab

21.6

307.7

977

245

G47.3

ICD-10 Finland

Sleep apnoea

2.8

307.7

7650

16325

N02CD01

ATC

erenumab; parenteral

26.5

307.7

620

126

B01AC24

ATC

ticagrelor; oral

24.3

307.7

623

138

K85

ICPC

Elevated blood pressure

7.7

307.7

4090

3088

C07AB02

ATC

metoprolol; systemic

17.5

307.7

6129

2151

201

Kela drug reimbursment

Chronic cardiac insufficiency

7.5

307.7

1053

761

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

307.7

8887

27971

N03AX11

ATC

topiramate; oral

7.7

307.7

1458

1038

XF402

NOMESCO Finland

ECG with work load test

3.9

307.7

2272

3227

N02BF01

ATC

gabapentin; oral

2.6

307.7

2440

5230

N02CC06

ATC

eletriptan; oral

4.5

307.7

2095

2547

I25

ICD-10 Finland

Chronic ischaemic heart disease

19.2

307.7

548

153

I50.1

ICD-10 Finland

Left ventricular failure

16.3

307.7

766

253

C09AA02

ATC

enalapril; systemic

43.0

307.7

5382

758

C10AA07

ATC

rosuvastatin; oral

2.6

307.7

8519

19509

103

Kela drug reimbursment

Diabetes, insulin-treated

4.6

307.7

7751

10528

N05AH04

ATC

quetiapine; oral

2.6

307.7

8815

20534

I47.1

ICD-10 Finland

Supraventricular tachycardia

4.4

307.7

1277

1592

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

10.8

307.7

1004

505

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

157.2

307.7

353

A10AB05

ATC

insulin aspart; parenteral

3.6

307.7

2504

3834

N02BE01

ATC

paracetamol; systemic, rectal

2.3

307.7

34797

151493

C09AA03

ATC

lisinopril; oral

61.8

307.7

722

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

8.6

307.7

1020

643

T90

ICPC

Diabetes non-insulin dependent

4.7

307.7

5984

7532

N06AX11

ATC

mirtazapine; oral

2.1

307.7

13070

39154

A10BK03

ATC

empagliflozin; oral

6.6

307.7

2301

1931

C07AB12

ATC

nebivolol; oral

44.5

307.7

889

108

N03AG01

ATC

valproic acid; systemic, rectal

2.8

307.7

2337

4569

I42.0

ICD-10 Finland

Dilated cardiomyopathy

30.4

307.7

493

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

9.7

307.7

1372

774

I50.0

ICD-10 Finland

Congestive heart failure

10.6

307.7

905

463

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

307.7

2764

6200

N05AX08

ATC

risperidone; systemic

2.5

307.7

2750

6103

E66

ICD-10 Finland

Obesity

3.0

307.7

2060

3824

E66.8

ICD-10 Finland

Other obesity

3.5

307.7

2356

3693

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

11.9

307.7

701

317

TK800

NOMESCO Finland

Hemodialysis

14.4

307.7

630

235

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

13.2

307.7

899

367

B01AF02

ATC

apixaban; oral

4.5

307.7

1847

2270

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

307.7

3198

7111

G43.9

ICD-10 Finland

Migraine, unspecified

3.6

307.7

3863

6109

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

13.7

307.7

2189

892

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

307.7

6334

17229

M03BX02

ATC

tizanidine; oral

1.7

307.7

23701

97810

A02BC03

ATC

lansoprazole; oral

1.8

307.7

7897

25516

E66.01

ICD-10 Finland

Obesity due to excess calories

3.0

307.7

4024

7524

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

194.1

307.7

399

N05CF02

ATC

zolpidem; oral

1.9

307.7

5923

17305

K80

ICPC

Cardiac arrhythmia NOS

3.3

307.7

2145

3526

B01AA03

ATC

warfarin; systemic

4.0

307.7

3355

4725

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

4.0

307.7

6562

9790

C09DA01

ATC

losartan and diuretics; oral

185.2

307.7

2592

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

10.2

307.7

1013

538

N05BA12

ATC

alprazolam; oral

2.6

307.7

3191

6913

R06.0

ICD-10 Finland

Dyspnoea

2.2

307.7

7901

21284

C09CA07

ATC

telmisartan; oral

35.8

307.7

1857

287

C09CA03

ATC

valsartan; oral

50.1

307.7

2196

245

H3603, E103,

ICD-10 Finland

13.7

307.7

517

202

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

307.7

6604

19333

N02AX02

ATC

tramadol; systemic, rectal

1.9

307.7

13998

45474

T89

ICPC

Diabetes insulin dependent

3.2

307.7

1627

2741

B01AC04

ATC

clopidogrel; oral

5.6

307.7

2687

2668

C09DA07

ATC

telmisartan and diuretics; oral

158.3

307.7

820

H02AB06

ATC

prednisolone; systemic

1.8

307.7

16139

57593

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

13.1

307.7

2917

1260

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

12.1

307.7

972

436

A10BA02

ATC

metformin; oral

4.3

307.7

7949

11554

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

12.0

307.7

755

340

N02CC05

ATC

almotriptan; oral

3.8

307.7

2125

3055

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

307.7

2637

5189

C10AX09

ATC

ezetimibe; oral

4.5

307.7

3495

4403

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

307.7

13955

40114

C03AA03

ATC

hydrochlorothiazide; oral

13.2

307.7

1543

643

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.8

307.7

7310

9298

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

8.2

307.7

4422

3133

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

307.7

8373

24996

T82

ICPC

Obesity

3.3

307.7

1652

2688

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

51.7

307.7

482

A12BA01

ATC

potassium chloride; oral

11.4

307.7

516

242

G44.2

ICD-10 Finland

Tension-type headache

2.0

307.7

5446

15284

137

Kela drug reimbursment

Uraemia requiring dialysis

96.4

307.7

307

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

13.2

307.7

1959

823

I10

ICD-10 Finland

Essential (primary) hypertension

34.0

307.7

21754

6802

I48

ICD-10 Finland

Atrial fibrillation and flutter

7.6

307.7

3554

2672

C09CA08

ATC

olmesartan medoxomil; oral

84.5

307.7

348

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

44.7

307.7

533

N06AB03

ATC

fluoxetine; oral

2.1

307.7

4304

11463

AA1AD

NOMESCO Finland

CT of head and brain

2.2

307.7

6967

18137

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

33.3

307.7

583

G43

ICD-10 Finland

Migraine

3.5

307.7

3590

5865

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

5.6

307.7

4420

4568

AN1

Coronary angiography

11.3

307.7

1570

765

N06AX12

ATC

bupropion; oral

2.5

307.7

3891

8751

C07AB03

ATC

atenolol; systemic

18.1

307.7

1005

301

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

11.5

307.7

778

364

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

307.7

5527

16496

205

Kela drug reimbursment

Chronic hypertension

36.5

307.7

5987

1010

A10BJ02

ATC

liraglutide; parenteral

11.5

307.7

811

381

A10BK01

ATC

dapagliflozin; oral

6.7

307.7

1670

1368

C07AB07

ATC

bisoprolol; oral

19.3

307.7

18801

8971

N05BA01

ATC

diazepam; systemic, rectal

2.5

307.7

4153

9297

R03AC02

ATC

salbutamol; inhalant

1.7

307.7

21251

83944

C07AG02

ATC

carvedilol; oral

49.5

307.7

1047

115

Angiography of the heart and coronary arteries

15.4

307.7

680

238

N03AX12

ATC

[U] gabapentin; oral

2.5

307.7

5187

11846

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

32.2

307.7

528

N06AX21

ATC

duloxetine; oral

2.8

307.7

4640

9419

C09DA06

ATC

candesartan and diuretics; oral

160.7

307.7

1911

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

31.6

307.7

460

N05AX12

ATC

aripiprazole; systemic

3.3

307.7

2494

4179

A10AE04

ATC

insulin glargine; parenteral

4.3

307.7

2894

3741

Z3231

NOMESCO Finland

Registered nurse

1.7

307.7

8902

29727

N02CC03

ATC

zolmitriptan; nasal, oral

3.4

307.7

2642

4289

C08CA02

ATC

felodipine; oral

50.0

307.7

1817

201

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.7

307.7

5088

10689

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

307.7

14123

54222

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

29.4

307.7

635

116

A02BC05

ATC

esomeprazole; systemic

1.7

307.7

13076

46389

J01FF01

ATC

clindamycin; systemic

1.7

307.7

8773

30159

A10AC01

ATC

insulin (human); parenteral

3.4

307.7

2481

4043

C09BA02

ATC

enalapril and diuretics; systemic

200.0

307.7

1422

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

307.7

7383

23791

C07AA07

ATC

sotalol; systemic

18.3

307.7

514

151

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

379.7

307.7

426

C09AA05

ATC

ramipril; oral

35.6

307.7

6603

1161

N06AX26

ATC

vortioxetine; oral

2.4

307.7

3577

8414

207

Kela drug reimbursment

Chronic arrhythmias

27.8

307.7

2433

491

C09DA03

ATC

valsartan and diuretics; oral

235.4

307.7

870

R42

ICD-10 Finland

Dizziness and giddiness

1.9

307.7

6338

19024

C10AA01

ATC

simvastatin; oral

3.3

307.7

8479

15786

N89

ICPC

Migraine

3.6

307.7

2484

3845

L04AD02

ATC

tacrolimus; systemic

26.3

307.7

539

110

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.1

307.7

4134

7531

M04AA01

ATC

allopurinol; systemic

3.5

307.7

2191

3493

C02EA02, ,

ATC

17.4

307.7

446

137

C01BC04

ATC

flecainide; systemic

22.6

307.7

642

153

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.8

307.7

8167

17526

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

4.1

307.7

4767

6708

I25.1

ICD-10 Finland

Atherosclerotic heart disease

7.2

307.7

3716

2976

N06AB10

ATC

escitalopram; oral

2.0

307.7

9761

29279

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.6

307.7

3031

6542

N05BA04

ATC

oxazepam; oral

2.4

307.7

10373

27044

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

307.7

15617

55526

TFP20

NOMESCO Finland

Cardiodefibrillation

15.5

307.7

1191

419

R5140

NOMESCO Finland

Monitoring the use of the aid

2.8

307.7

3020

5918

R00.2

ICD-10 Finland

Palpitations

2.8

307.7

3130

6253

R51.80

ICD-10 Finland

Headache

2.1

307.7

7018

19225

N02CC07

ATC

frovatriptan; oral

4.5

307.7

2475

3043

Z49.1

ICD-10 Finland

Extracorporeal dialysis

38.1

307.7

378

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

3.4

307.7

1824

2930

A11CC03

ATC

alfacalcidol; systemic

10.3

307.7

688

361

I49.3

ICD-10 Finland

Ventricular premature depolarization

3.7

307.7

1986

2941

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

108.6

307.6

285

M01AB05

ATC

diclofenac; systemic, rectal

1.5

301.7

23371

101862

G43.8

ICD-10 Finland

Other migraine

4.9

301.6

875

971

I20.01

ICD-10 Finland

Unstable angina

24.0

300.0

346

C09BA04

ATC

perindopril and diuretics; systemic

105.9

299.5

278

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

297.8

9133

32478

160

Kela drug reimbursment

exenatide

17.2

297.0

380

118

WX892

NOMESCO Finland

Monitored bed care

2.8

294.8

1892

3743

A02BC01

ATC

omeprazole; systemic

1.7

294.5

8001

27566

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

293.4

2102

4411

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

292.6

6001

19099

M10.9

ICD-10 Finland

Gout, unspecified

4.0

292.0

1062

1437

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

91.0

291.0

273

C07AB05

ATC

betaxolol; oral

29.0

290.6

320

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.5

289.0

2255

4941

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

287.5

4468

13005

S18

ICPC

Laceration/cut

1.5

286.9

13550

53165

A10AE06

ATC

insulin degludec; parenteral

3.6

286.5

1202

1814

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

286.4

7959

27557

A10BH05

ATC

linagliptin; oral

6.3

286.1

646

548

A10BJ05

ATC

dulaglutide; parenteral

10.8

285.4

450

224

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

284.6

4253

12210

R4110

NOMESCO Finland

Physiotherapy

1.6

284.4

8080

28130

I48.1

ICD-10 Finland

Persistent atrial fibrillation

14.5

282.5

386

142

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

282.2

10586

39432

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

281.1

3045

7736

N03AE01

ATC

clonazepam; systemic

2.8

279.2

1706

3281

B01AB05

ATC

enoxaparin; parenteral

1.6

278.7

8133

28490

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

276.7

6648

22111

ZXD05

NOMESCO Finland

Urgent procedure

1.6

276.6

10267

38118

N05AA02

ATC

levomepromazine; systemic

3.2

276.5

1340

2235

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

275.9

5807

18595

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.7

274.7

1819

3658

Z49.2

ICD-10 Finland

Other dialysis

133.8

274.2

251

N02CD02

ATC

galcanezumab; parenteral

27.2

274.0

306

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

272.6

6951

23487

E66.9

ICD-10 Finland

Obesity, unspecified

3.2

272.5

1346

2273

R02

ICPC

Shortness of breath/dyspnoea

2.0

272.2

3591

9849

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

14.6

271.7

370

135

M01AH05

ATC

etoricoxib; oral

1.5

271.3

21802

94811

N05BE01

ATC

buspirone; oral

3.8

271.2

1032

1447

H03AA01

ATC

levothyroxine sodium; systemic

1.7

270.8

6971

23611

P06

ICPC

Sleep disturbance

1.9

270.0

4479

13310

N06AB05

ATC

paroxetine; oral

2.5

269.8

2144

4737

C07AB08

ATC

celiprolol; oral

36.7

268.8

282

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

9.3

268.7

459

263

C10AA04

ATC

fluvastatin; oral

3.6

267.8

1128

1707

SPAT1263

SPAT

Sampling

1.5

267.7

14848

60012

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

265.7

2782

6963

A46

ICD-10 Finland

Erysipelas

2.1

264.5

3224

8578

Z2446

NOMESCO Finland

Social worker

2.3

260.9

2490

5987

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

260.2

3425

9379

A10BD07

ATC

metformin and sitagliptin; systemic

5.0

260.1

736

797

K87

ICPC

Hypertension complicated

36.4

259.9

273

K04

ICPC

Palpitations/awareness of heart

2.8

259.5

1600

3091

A28

ICPC

Limited function/disability NOS

2.2

259.1

2814

7149

J01FA06

ATC

roxithromycin; oral

1.5

258.4

12636

49683

P01AB01

ATC

metronidazole; oral, rectal

1.5

258.2

13706

54801

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.9

258.0

1515

2846

A10AA02, ,

ATC

3.6

256.2

1047

1549

L28

ICPC

Limited function/disability (L)

2.0

256.2

3627

10196

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

255.9

5106

16063

C07FB02

ATC

metoprolol and felodipine; systemic

296.9

255.6

334

N07BB01

ATC

disulfiram; oral

2.9

255.3

1504

2830

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

254.1

7331

25532

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

4.6

253.7

787

929

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

253.0

5057

15914

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

253.0

7768

27475

J01DA01

ATC

[U] cefalexin

1.4

252.8

22122

97186

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

8.7

252.7

452

279

N18.0

ICD-10 Finland

End-stage renal disease

36.9

251.0

263

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.1

250.5

686

719

A10AA01, ,

ATC

3.8

249.5

968

1377

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

249.2

1718

3528

SPAT1310

SPAT

Counselling related to known health issue

1.5

248.3

10685

40818

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

247.8

3941

11528

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

247.5

6133

20509

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

244.7

7981

28616

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.1

244.2

2807

7290

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

24.2

244.2

281

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.5

243.8

1038

1582

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.4

243.5

1098

1743

N19

ICD-10 Finland

Unspecified kidney failure

6.8

243.3

516

405

J01MA02

ATC

ciprofloxacin; systemic

1.5

243.1

11066

42746

UJF32

NOMESCO Finland

Coloscopy

1.7

242.4

6469

22052

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

240.0

5820

19333

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

239.5

28088

129601

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

239.4

2187

5152

ZY010

NOMESCO Finland

Hospital outpatient

2.2

239.2

2394

5871

Z49.0

ICD-10 Finland

Preparatory care for dialysis

68.1

238.9

230

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

235.8

235.0

310

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

235.0

13839

56209

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

7.4

234.6

467

337

B01AC06

ATC

acetylsalicylic acid; oral

15.3

234.3

313

109

N06AX22

ATC

agomelatine; oral

3.3

233.7

1114

1836

F40.1

ICD-10 Finland

Social phobias

2.8

233.5

1433

2759

M25.5

ICD-10 Finland

Pain in joint

1.5

232.5

11028

42886

R60.0

ICD-10 Finland

Localized oedema

2.1

232.4

2671

6932

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.9

231.8

876

1221

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

3.8

229.7

897

1282

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

229.7

20720

90843

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

229.6

10346

39788

OAB50, ,

SPAT

2.9

229.2

1337

2500

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

227.4

9812

37378

N06AX05

ATC

trazodone; oral

3.6

227.0

947

1422

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

14.7

226.5

308

112

R11

ICD-10 Finland

Nausea and vomiting

2.0

226.1

2995

8204

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

13.6

226.0

317

124

H02AB04

ATC

methylprednisolone; systemic

1.8

225.7

4024

12197

WX002

NOMESCO Finland

Sedation and analgesia

1.7

225.4

4935

15909

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

225.2

1790

3948

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

224.0

19924

86983

XF602

NOMESCO Finland

Bloodpressure monitoring

10.4

223.8

358

183

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

10.4

223.2

358

184

SPAT1100

SPAT

Long-term monitoring of blood pressure

3.4

222.9

997

1573

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

7.4

222.4

443

320

SPAT1240

SPAT

Therapeutic discussion

1.7

222.1

4922

15917

V03AE01

ATC

polystyrene sulfonate; oral

17.3

222.0

283

WX780

NOMESCO Finland

Remote monitoring CPAP

3.0

221.9

1234

2242

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

14.8

221.5

300

108

C10AA03

ATC

pravastatin; oral

3.4

220.9

978

1532

R01AD09

ATC

mometasone; nasal

1.4

220.8

17190

73245

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

220.8

7093

25260

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

220.6

11362

44828

C07AG01

ATC

labetalol; systemic

10.8

220.6

347

172

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

4.4

219.1

703

855

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

2.7

217.5

1486

3034

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

11.3

217.3

333

157

N05AF03

ATC

chlorprothixene; systemic

3.5

217.0

935

1437

L17

ICPC

Foot/toe symptom/complaint

1.5

216.7

8643

32318

Z3226

NOMESCO Finland

Physiotherapist

1.7

216.4

5221

17277

I35.0

ICD-10 Finland

Aortic (valve) stenosis

4.6

215.8

660

769

C09BA05

ATC

ramipril and diuretics; oral

170.5

215.4

289

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

214.9

3720

11161

3051, ,

Kela drug reimbursment

9.5

213.1

361

204

J01MA12

ATC

levofloxacin; systemic

1.7

213.0

4531

14471

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

212.8

2197

5452

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.5

212.0

1666

3653

Z71.8

ICD-10 Finland

Other specified counselling

1.5

211.9

11525

45882

H36.01

ICD-10 Finland

Diabetic maculopathy

7.3

211.8

425

310

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.3

210.7

1908

4472

B03XA02

ATC

darbepoetin alfa; parenteral

6.7

210.7

452

360

L03

ICPC

Low back symptom/complaint

1.5

210.4

9388

35916

AN3

Balloon angioplasty and metallic stent

19.2

210.2

259

P76

ICPC

Depressive disorder

2.0

209.4

2964

8307

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

208.8

2621

7030

TFP35

NOMESCO Finland

Electroanatomical mapping

10.1

208.8

341

181

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

94.4

208.4

195

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.7

207.7

4992

16488

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.8

207.5

800

1132

SPAT1301

SPAT

No procedures

1.5

207.4

9714

37515

C09BA03

ATC

lisinopril and diuretics; oral

242.1

207.2

273

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

15.1

207.1

278

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

86.5

207.0

195

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

4.8

206.8

609

685

K84

ICPC

Heart disease other

8.6

206.2

371

231

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

206.1

2627

7086

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

205.5

2861

7970

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

203.4

3006

8550

I50

ICD-10 Finland

Heart failure

16.2

202.9

265

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

47.2

202.7

204

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

34.5

201.8

214

N02CC02

ATC

naratriptan; oral

4.2

201.6

678

859

I20.00

ICD-10 Finland

Unstable angina

10.3

200.7

323

167

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

200.6

1448

3041

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

200.0

1716

3922

P74

ICPC

Anxiety disorder/anxiety state

2.1

198.5

2171

5514

A01

ICPC

Pain general/multiple sites

2.0

198.1

2556

6922

M01AC06

ATC

meloxicam; systemic, rectal

1.5

196.8

10028

39312

SPAT1252

SPAT

Overall medication plan or its review

2.7

196.5

1286

2564

A11

ICPC

Chest pain NOS

2.3

195.1

1852

4430

M79.7

ICD-10 Finland

Fibromyalgia

2.8

194.2

1166

2215

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

193.5

1411

2978

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

193.3

11189

44910

SPAT1260

SPAT

Consultation of another employee

1.6

193.2

5238

17833

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

5.9

192.8

460

416

I49.1

ICD-10 Finland

Atrial premature depolarization

3.5

192.7

819

1246

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

192.6

2442

6568

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

192.4

2230

5795

E87.6

ICD-10 Finland

Hypokalaemia

4.1

192.3

677

891

C08CA10

ATC

nilvadipine; oral

332.8

192.2

250

WX402

NOMESCO Finland

General anaesthesia

1.5

192.2

6881

25037

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.0

192.2

1028

1823

R50.9

ICD-10 Finland

Fever, unspecified

1.7

192.1

4934

16562

I20.90

ICD-10 Finland

Angina pectoris, unspecified

7.2

191.9

388

286

B05DA

ATC

Isotonic solutions

169.8

190.8

256

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

190.7

15167

64349

Single vessel balloon catheter extension

48.4

190.4

191

R03DC03

ATC

montelukast; oral

1.6

190.4

5578

19357

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

189.7

17776

77467

B01AF01

ATC

rivaroxaban; oral

2.2

189.1

2006

5029

A02BA02

ATC

ranitidine; systemic

1.7

189.0

4336

14116

R07.3

ICD-10 Finland

Other chest pain

2.0

188.8

2667

7460

H04AA01

ATC

glucagon; nasal, parenteral

2.8

188.6

1136

2162

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

188.2

5849

20583

R06AE07

ATC

cetirizine; oral

1.4

188.2

16459

70893

N05AN01

ATC

lithium; oral

3.1

187.2

963

1666

M79.1

ICD-10 Finland

Myalgia

1.6

187.1

5092

17341

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

186.2

3842

12133

WZC30

NOMESCO Finland

Teaching

1.7

186.0

4066

13056

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

185.7

7971

30134

N06AX03

ATC

mianserin; oral

2.8

185.1

1176

2306

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

185.0

3373

10263

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

56.7

184.2

181

G44.0

ICD-10 Finland

Cluster headache syndrome

5.5

184.1

473

464

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

184.0

6699

24438

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.1

183.1

642

842

P99

ICPC

Psychological disorders other

2.6

182.8

1322

2778

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

182.0

1955

4925

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.5

180.9

565

671

P29

ICPC

Psychological sympt/compl other

1.8

180.8

3351

10244

H3601, E103,

ICD-10 Finland

6.2

180.8

414

357

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

180.5

1849

4567

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.1

180.3

496

522

SPAT1153

SPAT

Removal of sutures

1.5

180.0

8195

31328

D07AC01

ATC

betamethasone; topical

1.4

179.9

11126

45078

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.7

179.8

1181

2358

S97

ICPC

Chronic ulcer skin

2.9

179.4

1043

1944

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.7

178.3

1135

2228

A10BX07

ATC

[U] liraglutide

20.4

178.2

215

K76

ICPC

Ischaemic heart dis without angina

16.1

178.0

233

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

6.3

177.3

399

337

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

176.7

2745

7927

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

13.3

176.5

250

100

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

12.6

176.4

256

108

WX290

NOMESCO Finland

Other blockage of nerve

1.4

176.2

19746

88131

SPAT1254

SPAT

Administration of medicine

1.7

176.2

4274

14109

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

176.2

9298

36561

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

5.5

175.7

446

432

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

175.3

11249

45834

H03BB01

ATC

carbimazole; oral

2.6

175.2

1198

2444

Coronary artery bypass surgery

37.5

175.2

183

WX723

NOMESCO Finland

CPAP therapy

2.8

175.0

1109

2171

WX722

NOMESCO Finland

PEEP

3.1

174.9

881

1504

B05DB

ATC

Hypertonic solutions

176.6

174.1

233

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

173.9

1863

4687

F41.00

ICD-10 Finland

Moderate panic disorder

3.4

173.7

791

1263

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

11.0

173.6

270

131

K25

ICPC

Fear of hypertension

3.4

172.0

772

1220

N05BA06

ATC

lorazepam; systemic, sublingual

2.5

172.0

1284

2741

C02DE04, ,

ATC

17.2

171.2

219

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.2

170.5

578

737

R03BB04

ATC

tiotropium bromide; inhalant

2.1

169.1

1842

4664

N05CD07

ATC

temazepam; oral

2.0

169.1

2205

5985

SPAT1255

SPAT

Intravenous administration of medicine

2.3

168.7

1618

3884

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.9

168.6

947

1729

P01

ICPC

Feeling anxious/nervous/tense

1.5

168.4

6297

23060

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.6

167.8

1207

2528

ZXE00

NOMESCO Finland

One hour or less

1.4

167.7

12533

52325

I49.5

ICD-10 Finland

Sick sinus syndrome

5.9

167.5

403

368

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

167.1

4151

13778

K05

ICPC

Irregular heartbeat other

3.8

167.1

650

926

N02AA05

ATC

oxycodone; systemic

1.8

167.0

3379

10593

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.7

167.0

665

964

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

167.0

3067

9341

R55

ICD-10 Finland

Syncope and collapse

1.9

166.9

2536

7265

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.3

166.9

1463

3373

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

166.6

1669

4082

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

10.0

165.9

271

144

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

3.2

165.5

819

1382

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

165.4

2204

6029

N05AB03

ATC

perphenazine; systemic, rectal

2.7

164.4

1077

2147

L01

ICPC

Neck symptom/complaint

1.6

164.3

5255

18568

AA1

Conventional CABG

60.8

164.2

160

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

4.3

164.1

542

676

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

164.1

1894

4907

K77

ICPC

Heart failure

24.0

164.0

189

M02AA07

ATC

piroxicam; topical

1.4

163.9

9026

35694

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

16.6

163.8

212

N02CD06

ATC

rimegepant; oral

18.0

163.7

206

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.2

163.7

804

1350

A10AD01

ATC

insulin (human); parenteral

4.1

163.6

571

746

A06AD11

ATC

lactulose; oral

1.8

163.4

3032

9260

ZXA00

NOMESCO Finland

Right side

1.5

163.2

6220

22856

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

12.4

163.1

239

103

J01CA04

ATC

amoxicillin; systemic

1.4

162.3

32844

159685

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

161.9

8270

32238

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.0

161.4

883

1587

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

9.5

161.1

272

153

A10BG03

ATC

pioglitazone; oral

6.3

161.1

365

311

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

160.8

6086

22321

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.4

160.4

1367

3110

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

20.9

160.1

192

L04AD01

ATC

ciclosporin; systemic

3.9

160.0

603

838

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.1

159.4

834

1458

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

159.3

2792

8376

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

159.2

3740

12220

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

158.1

2829

8541

R01AD58

ATC

fluticasone, combinations; nasal

1.4

158.1

9789

39494

Z2445

NOMESCO Finland

Psychologist

2.1

156.8

1738

4430

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.3

156.4

411

413

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

156.0

6977

26475

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

17.3

155.2

198

SPAT1104

SPAT

Monitoring of emergency patient

2.2

155.2

1544

3763

P15

ICPC

Chronic alcohol abuse

2.8

155.1

964

1866

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

34.9

155.0

164

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

154.8

28841

137630

GD1LA

NOMESCO Finland

11.0

154.7

240

116

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

154.6

1896

5026

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

154.5

3342

10669

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.9

154.3

873

1601

R03BA02

ATC

budesonide; inhalant

1.5

154.3

5691

20740

162

Kela drug reimbursment

liraglutide

18.2

153.4

192

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.0

153.1

2046

5599

SPAT1081

SPAT

Cardiorespiratory global assessment

2.9

152.3

877

1625

H36.00

ICD-10 Finland

Diabetic background retinopathy

5.1

152.2

415

433

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

152.1

2884

8859

SFA30

NOMESCO Finland

Three-surface restoration

1.4

151.9

13609

58256

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

151.2

9742

39522

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

151.0

2493

7333

Z2221

NOMESCO Finland

Medical doctor

1.4

150.9

8751

34849

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

150.8

8661

34432

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

150.4

1959

5310

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

64.3

149.7

145

N06AA10

ATC

nortriptyline; systemic

3.7

149.2

594

861

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.4

149.0

667

1052

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.3

148.5

1365

3213

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.1

148.5

756

1299

F61.0

ICD-10 Finland

Mixed personality disorders

3.2

148.4

720

1199

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.8

148.4

434

485

R05

ICPC

Cough

1.4

148.2

7758

30310

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

147.6

2648

7996

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

63.4

147.4

143

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

4.1

147.3

515

674

C09AA01

ATC

captopril; oral

23.8

147.3

170

R01AD12

ATC

fluticasone furoate; nasal

1.4

147.1

12348

52263

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

146.9

963

1920

SPAT1216

SPAT

Assessment of functional ability

1.7

146.9

2980

9336

J02AC01

ATC

fluconazole; systemic

1.3

146.7

13794

59401

M48.0

ICD-10 Finland

Spinal stenosis

2.0

146.3

1867

5022

R96

ICPC

Asthma

1.8

146.3

2551

7634

K02.1

ICD-10 Finland

Caries of dentine

1.3

146.2

23646

110017

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

146.0

1511

3743

J45

ICD-10 Finland

Asthma

1.7

145.8

3170

10128

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

145.7

2747

8420

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

144.4

8567

34214

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

144.4

3128

9983

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

3.0

144.0

773

1373

F34.1

ICD-10 Finland

Dysthymia

2.3

143.8

1331

3143

H3600, E103,

ICD-10 Finland

4.3

143.6

468

577

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

7.2

143.6

292

217

SGA01

NOMESCO Finland

Emergency treatment

1.5

143.4

6235

23482

N01

ICPC

Headache

1.5

142.6

5052

18222

R01AD08

ATC

fluticasone; nasal

1.4

142.3

9956

40881

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

142.2

11949

50520

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

141.5

3961

13521

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

10.6

141.1

224

113

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.4

140.8

1168

2623

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

38.8

140.7

146

CKC12

NOMESCO Finland

Photocoagulation of retina

2.5

140.5

1054

2254

P03

ICPC

Feeling depressed

1.6

140.3

4562

16134

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

140.2

4097

14129

B02AA02

ATC

tranexamic acid; systemic

1.5

140.1

4723

16842

I44.2

ICD-10 Finland

Atrioventricular block, complete

5.6

139.9

348

330

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

3.0

139.3

752

1340

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

139.0

2560

7787

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

139.0

5514

20366

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

126.4

138.9

190

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.6

138.7

1009

2124

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

138.6

1304

3101

M03AX01

ATC

botulinum toxin; parenteral

3.5

138.3

600

926

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

59.8

138.3

135

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.5

137.0

1041

2240

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

137.0

1333

3216

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

136.8

1011

2146

A10BX04

ATC

[U] exenatide

17.9

136.7

172

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

5.3

136.6

363

369

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.9

136.6

2109

6064

AP1

Catheterization of the left side of the heart

18.2

136.5

171

R03BA05

ATC

fluticasone; inhalant

1.5

136.4

5969

22486

R04.0

ICD-10 Finland

Epistaxis

2.2

136.1

1371

3357

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

136.1

3792

12922

Catheterization and pressure measurement of the left side of the heart

11.9

135.7

202

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

16.4

135.5

176

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

135.4

2301

6825

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

135.4

4000

13825

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

135.3

3008

9661

C07AB04

ATC

acebutolol; systemic

23.2

135.1

157

UKC02

NOMESCO Finland

Cystoscopy

1.7

134.8

3053

9856

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.5

134.6

567

857

280

Kela drug reimbursment

Clopidogrel

68.6

134.1

129

P72

ICPC

Schizophrenia

3.2

133.8

669

1136

C08CA03

ATC

isradipine; systemic

58.0

133.7

131

M10.0

ICD-10 Finland

Idiopathic gout

4.2

133.7

454

580

K04.0

ICD-10 Finland

Pulpitis

1.6

133.5

3758

12835

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.6

132.9

544

805

SFA20

NOMESCO Finland

Two-surface restoration

1.3

132.7

22377

104041

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

131.6

3810

13099

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

131.3

26846

127993

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

131.0

2277

6800

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

130.7

2094

6092

B01AE07

ATC

dabigatran etexilate; oral

4.0

130.7

471

632

A10BJ01

ATC

exenatide; parenteral

12.9

130.4

187

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

8.5

130.3

235

147

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

6.9

130.3

274

213

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.2

130.0

650

1104

H3601, E113,

ICD-10 Finland

12.2

129.9

191

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

5.0

129.9

359

380

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.4

129.7

588

936

R03BA01

ATC

beclometasone; inhalant

1.6

129.6

3801

13107

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

11.1

129.1

199

ZX120

NOMESCO Finland

Intravenous

1.8

129.0

2412

7366

250, ,

Kela drug reimbursment

117.7

128.7

177

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.6

128.3

913

1900

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

128.3

2593

8102

SPAT1377

SPAT

Polysomnography

2.6

128.0

887

1821

M10

ICD-10 Finland

Gout

3.0

127.8

682

1207

J01FA09

ATC

clarithromycin; systemic

1.4

127.4

10274

43008

M01AH01

ATC

celecoxib; oral

1.6

127.3

4113

14505

A10BD20

ATC

metformin and empagliflozin; oral

6.9

127.2

267

207

ZXA05

NOMESCO Finland

Left side

1.5

127.0

5654

21342

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.0

126.6

699

1263

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.3

126.3

584

942

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

125.8

1138

2658

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.9

125.3

457

619

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.7

125.1

822

1640

R51

ICD-10 Finland

Headache

1.8

124.1

2159

6447

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

123.3

3891

13640

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

123.3

1633

4448

R52.2

ICD-10 Finland

Other chronic pain

2.4

123.2

1021

2291

R4190

NOMESCO Finland

Nutritional therapy

2.2

123.0

1291

3215

S10

ICPC

Boil/carbuncle

2.0

122.8

1681

4634

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.9

122.3

697

1283

G25.0

ICD-10 Finland

Essential tremor

3.8

122.3

473

671

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.7

122.2

2747

8842

R52.9

ICD-10 Finland

Pain, unspecified

1.7

122.0

2860

9309

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

121.9

2134

6384

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

121.6

152

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.0

121.5

438

588

N04BC05

ATC

pramipexole; oral

2.0

121.2

1552

4175

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

120.7

1146

2735

N06AA12

ATC

doxepin; systemic

2.4

120.7

1014

2290

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

120.6

1698

4726

N06AG02

ATC

moclobemide; oral

2.4

120.6

1008

2271

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

120.4

21625

100778

N06BA04

ATC

methylphenidate; oral

1.9

120.1

1825

5215

C09DX04

ATC

valsartan and sacubitril; oral

+∞

120.0

150

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

119.8

4121

14727

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2.8

119.4

738

1424

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

31.2

119.2

129

SFA10

NOMESCO Finland

One-surface restoration

1.3

119.0

20917

97150

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

119.0

3278

11121

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.0

118.9

637

1130

E0000UV, ,

ATC

1.3

118.6

14233

62923

CKC15

NOMESCO Finland

Panretinal photocoagulation

9.7

118.5

197

108

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.7

118.5

463

662

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

2.5

118.2

875

1858

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

9.6

118.2

198

110

EBA00

NOMESCO Finland

Extraction of tooth

1.3

118.1

12765

55631

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

118.0

2286

7050

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.2

118.0

577

966

ZY000

NOMESCO Finland

Hospital inpatient

3.1

117.8

592

1009

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

117.5

1783

5091

C02EA03, ,

ATC

40.2

117.3

121

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

29.6

117.0

128

J01MA14

ATC

moxifloxacin; systemic

1.8

116.7

2108

6365

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

116.6

1426

3771

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.4

116.5

258

214

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

116.2

1430

3790

H02AB07

ATC

prednisone; oral

1.6

115.9

3345

11473

TK820

NOMESCO Finland

Peritoneal dialysis

95.8

115.8

162

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.3

115.4

547

897

V03AE02

ATC

sevelamer; oral

120.1

115.2

158

L08

ICPC

Shoulder symptom/complaint

1.4

114.7

5763

22223

OAB93, ,

SPAT

1.7

114.6

2432

7698

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.8

114.6

716

1390

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.3

114.4

1068

2529

R80

ICD-10 Finland

Isolated proteinuria

7.1

114.1

234

176

ACC51

NOMESCO Finland

Release of median nerve

1.8

114.1

1877

5504

M01AX17

ATC

nimesulide; oral

1.5

114.0

5022

18882

J01EA01

ATC

trimethoprim; systemic

1.4

113.9

7560

30595

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

113.4

1475

3990

G04CA02

ATC

tamsulosin; oral

1.5

113.3

3743

13247

J01FA10

ATC

azithromycin; systemic

1.3

113.2

22417

105370

3025

Kela drug reimbursment

Calcium carbonate

21.6

113.0

134

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

112.8

12046

52331

H05BX01

ATC

cinacalcet; oral

19.7

112.3

137

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.7

111.9

746

1500

R06.5

ICD-10 Finland

Mouth breathing

1.7

111.9

2480

7944

B03XA01

ATC

erythropoietin; parenteral

9.4

111.9

190

108

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

3.3

111.8

532

875

K29

ICPC

Cardiovascular sympt/complt other

3.0

111.7

615

1109

K08.3

ICD-10 Finland

Retained dental root

1.9

111.7

1709

4893

R31

ICD-10 Finland

Unspecified haematuria

1.8

111.6

1837

5387

D11

ICPC

Diarrhoea

1.5

111.4

4494

16596

H02AB09

ATC

hydrocortisone; systemic

2.6

111.3

774

1592

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

111.0

1612

4534

A10BH02

ATC

vildagliptin; oral

7.1

111.0

228

172

A04

ICPC

Weakness/tiredness general

1.5

110.9

4617

17158

4019X

ICD-9 Finland

Essential hypertension, Unspecified

5.6

110.9

277

264

R03AC03

ATC

terbutaline; inhalant

1.5

110.6

4154

15114

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

12.9

110.3

158

A02BC04

ATC

rabeprazole; oral

1.7

109.8

2406

7682

C08CA07

ATC

nisoldipine; oral

45.4

109.7

111

OAA65, ,

SPAT

1.4

109.4

7394

29987

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

35.9

109.3

115

SPAT1229

SPAT

Assessment of need for aid

2.1

109.1

1293

3377

XFE00

NOMESCO Finland

Epicardial ultrasonography

4.0

109.1

390

520

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.0

108.9

1376

3682

N04AA02

ATC

biperiden; systemic

3.1

108.6

550

942

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

5.5

108.2

274

265

K07

ICPC

Swollen ankles/oedema

2.9

108.0

630

1176

N17

ICPC

Vertigo/dizziness

1.6

108.0

2926

9876

L86

ICPC

Back syndrome with radiating pain

1.9

107.9

1513

4204

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.3

107.7

938

2153

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.0

107.5

1432

3906

F41.01

ICD-10 Finland

Severe panic disorder

4.8

107.4

314

351

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

107.2

9206

38719

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

107.2

134

XG466

NOMESCO Finland

Sleep oxymetry

2.9

107.1

611

1126

E87.5

ICD-10 Finland

Hyperkalaemia

6.8

107.0

225

175

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

106.9

752

1556

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.0

106.8

567

1000

196

Kela drug reimbursment

Paricalcitol and cinacalcet

153.7

106.8

144

I34.1

ICD-10 Finland

Mitral (valve) prolapse

3.4

106.8

467

725

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

106.8

11931

52057

P19

ICPC

Drug abuse

3.2

106.6

514

853

P18

ICPC

Medication abuse

5.1

106.4

291

305

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

106.1

1543

4341

K22

ICPC

Risk factor cardiovascular disease

2.4

106.0

884

1989

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.2

105.8

514

857

J20

ICD-10 Finland

Acute bronchitis

1.6

105.7

2925

9921

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

11.1

105.7

163

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

105.7

1774

5233

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

105.4

36076

181224

C07BB02

ATC

metoprolol and thiazides; systemic

151.5

105.2

142

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

105.1

1583

4507

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

105.0

2979

10165

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

104.8

2329

7463

XF640, ,

NOMESCO Finland

3.9

104.4

379

512

ZXA10

NOMESCO Finland

Bilateral

1.5

104.3

4379

16287

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

17.2

104.3

133

TK810

NOMESCO Finland

Hemofiltration

14.5

104.2

142

R4120

NOMESCO Finland

Occupational therapy

1.9

104.2

1670

4853

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.7

104.1

695

1399

SPAT1058

SPAT

PEF monitoring instruction

1.8

103.9

1942

5921

C09CA02

ATC

eprosartan; oral

149.3

103.7

140

R06AX27

ATC

desloratadine; oral

1.3

103.3

10985

47568

M54.2

ICD-10 Finland

Cervicalgia

1.7

102.6

2321

7473

F10.24

ICD-10 Finland

Alcohol depence active use

3.5

102.5

446

690

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

102.2

2564

8482

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

101.8

3989

14626

E26.0

ICD-10 Finland

Primary hyperaldosteronism

23.9

101.5

117

A10BD03

ATC

metformin and rosiglitazone; systemic

9.9

101.5

167

K30

ICD-10 Finland

Functional dyspepsia

1.6

101.3

3249

11407

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.9

101.2

571

1045

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

100.8

1076

2696

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

7.5

100.7

197

139

SPAT1234

SPAT

Support of social functional capacity

2.2

100.7

1007

2456

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

100.1

2169

6899

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

100.1

3464

12368

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

99.8

1531

4385

F32

ICD-10 Finland

Depressive episode

1.7

99.7

2128

6740

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

9.8

99.6

165

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

92.4

99.1

139

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

99.1

13383

59690

C10AB05

ATC

fenofibrate; oral

4.5

98.9

307

363

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

98.8

1260

3382

Z94.1

ICD-10 Finland

Heart transplant status

52.1

98.7

R05

ICD-10 Finland

Cough

1.4

98.7

6105

24353

N05AE04

ATC

ziprasidone; systemic

4.3

98.4

319

392

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.2

98.0

479

802

K04.08

ICD-10 Finland

Other specified pulpit

1.6

97.2

2951

10227

R03BA08

ATC

ciclesonide; inhalant

1.6

97.1

2405

7927

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

97.1

503

874

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

6.3

97.1

218

184

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.9

96.9

357

488

K83

ICPC

Heart valve disease NOS

10.8

96.7

151

A10AD05

ATC

insulin aspart; parenteral

6.3

96.7

218

185

N07BA03

ATC

varenicline; oral

1.9

96.6

1495

4293

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.3

96.6

318

396

H3603, E113,

ICD-10 Finland

14.1

96.6

133

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.0

96.4

516

915

C02LM02, ,

ATC

51.0

96.4

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

14.3

96.4

132

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

13.5

96.2

135

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

96.2

2059

6526

A99

ICPC

Disease/condition unspecnature/site

1.7

96.1

2331

7641

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

96.1

2454

8152

FL1AC

NOMESCO Finland

Left cardioangiography

8.4

95.9

174

110

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.7

95.6

609

1195

SPAT1283

SPAT

Restricted health certificate

1.3

95.3

8476

35729

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.4

95.2

757

1665

A08

ICPC

Swelling

2.3

95.1

855

1991

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

95.0

1412

4001

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

12.3

94.9

139

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

8.8

94.7

167

101

J01CF05

ATC

flucloxacillin; systemic

1.8

94.4

1759

5355

5AB14, ,

NOMESCO Finland

45.9

94.0

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.6

94.0

2902

10093

G43.2

ICD-10 Finland

Status migrainosus

7.7

93.7

180

124

I20.91

ICD-10 Finland

Angina pectoris, unspecified

19.5

93.3

114

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

92.9

2315

7641

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

92.6

1824

5644

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.1

92.3

1097

2867

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.3

92.3

814

1879

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

92.2

8911

37978

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

7.3

91.6

183

133

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

7.0

91.5

188

142

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.7

91.3

355

506

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

91.3

2224

7296

A29

ICPC

General symptom/complaint other

1.5

91.0

3030

10717

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

90.9

5934

23846

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

90.9

2956

10400

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

90.5

2725

9418

SPAT1281

SPAT

Other administrative function

1.7

90.5

2187

7159

KMAK, ,

NOMESCO Finland

1.2

90.3

19249

90203

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

90.2

1536

4548

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

90.0

1863

5847

R01AD01

ATC

beclometasone; nasal

1.4

89.6

4376

16724

J01CA08

ATC

pivmecillinam; oral

1.3

89.5

13297

59799

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

89.5

1402

4042

K99

ICPC

Cardiovascular disease other

3.8

89.3

338

472

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

3.8

89.0

335

466

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.9

88.9

507

934

D07AC13

ATC

mometasone; topical

1.3

88.9

8523

36252

N30.0

ICD-10 Finland

Acute cystitis

1.4

88.8

4706

18249

C02DE02, ,

ATC

12.5

88.6

129

WX882

NOMESCO Finland

High dependency care

2.5

88.5

681

1474

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

88.4

5485

21850

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

88.3

2240

7425

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

88.1

4166

15821

SPAT1312

SPAT

General health counselling

1.3

87.9

10958

48223

R25.1

ICD-10 Finland

Tremor, unspecified

2.6

87.8

604

1235

R4110, ,

SPAT

1.7

87.8

1893

6009

J01FA15

ATC

telithromycin; oral

1.6

87.8

2641

9125

S06.0

ICD-10 Finland

Concussion

1.5

87.8

3329

12105

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

8.8

87.5

154

PD5BD

NOMESCO Finland

Extensive CT of aorta

5.2

87.5

233

238

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.9

87.4

498

917

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.5

87.4

651

1387

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.5

87.3

643

1362

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

126.5

87.2

119

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

87.0

1848

5841

Z72.2

ICD-10 Finland

Drug use

4.0

87.0

313

420

K90

ICPC

Stroke/cerebrovascular accident

3.7

86.9

338

482

P16

ICPC

Acute alcohol abuse

2.8

86.5

521

991

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

86.4

1261

3549

L15

ICPC

Knee symptom/complaint

1.3

86.4

6451

26455

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.3

86.2

804

1903

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

85.7

9897

43109

I49

ICD-10 Finland

Other cardiac arrhythmias

3.0

85.7

465

832

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

0.6

85.6

1238

11571

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

11.6

85.6

129

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

85.5

1785

5614

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

85.1

2246

7517

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

45.7

85.0

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

4.6

85.0

258

299

L02

ICPC

Back symptom/complaint

1.5

85.0

3339

12225

L13

ICPC

Hip symptom/complaint

1.5

85.0

3790

14230

KBV00

NOMESCO Finland

Insertion of stent into ureter

6.3

84.9

190

160

N05AX15

ATC

cariprazine; oral

4.9

84.9

238

256

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

84.7

7679

32377

IGV01

NOMESCO Finland

Psychiatric network contact

2.9

84.7

483

890

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

84.7

900

2251

N06AA06

ATC

trimipramine; systemic

2.7

84.6

535

1046

H3602, E103,

ICD-10 Finland

9.6

84.5

141

R33

ICD-10 Finland

Retention of urine

1.9

84.4

1263

3585

SPAT1101

SPAT

Orthostatic test

2.8

84.2

516

991

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.6

84.2

599

1247

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

83.9

1395

4098

B01AF03

ATC

edoxaban; oral

5.4

83.9

216

213

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

11.9

83.8

125

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

83.7

2250

7564

L16

ICPC

Ankle symptom/complaint

1.5

83.5

3516

13051

J01DA09

ATC

[U] cefadroxil

1.3

83.4

8418

36008

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

16.4

83.2

108

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.8

83.2

1426

4230

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.2

82.7

787

1879

R06AX22

ATC

ebastine; oral

1.4

82.7

5471

22003

321

Kela drug reimbursment

Paricalcitol and cinacalcet

13.2

82.6

117

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

82.5

6266

25740

XA800

NOMESCO Finland

Neuropsychological investigation

1.9

82.5

1180

3299

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

82.4

2073

6854

Q23.11

ICD-10 Finland

Bicuspid aortic valve

4.8

82.3

240

268

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

10.0

82.3

134

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

82.3

939

2416

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

82.3

2278

7713

A03

ICPC

Fever

1.3

82.2

6830

28429

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.0

82.1

440

781

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

82.1

3023

10918

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.4

82.0

661

1464

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

81.9

3005

10843

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

81.9

7612

32186

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.0

81.9

430

754

R12

ICD-10 Finland

Heartburn

1.6

81.7

2348

8022

W78

ICPC

Pregnancy

0.7

81.6

4880

33921

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

13.1

81.6

116

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.6

81.4

334

496

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

80.9

2979

10757

RS220, ,

NOMESCO Finland

3.1

80.9

411

706

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

80.6

1920

6258

AN2

Balloon angioplasty, including several vessels

3.7

80.5

316

454

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

80.4

515

1014

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.3

80.4

733

1718

I15.8

ICD-10 Finland

Other secondary hypertension

13.3

80.1

113

G54.0

ICD-10 Finland

Brachial plexus disorders

2.1

80.0

876

2217

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

80.0

3221

11845

K06.18

ICD-10 Finland

Another gingival hyperplasia

8.5

79.7

143

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.9

79.7

457

845

M54.3

ICD-10 Finland

Sciatica

1.8

79.5

1419

4261

V03AE03

ATC

lanthanum carbonate; oral

85.0

79.3

112

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.9

79.2

463

866

I20

ICD-10 Finland

Angina pectoris

6.6

79.2

170

136

PD5AD

NOMESCO Finland

CT of aorta

3.8

79.1

302

425

A10BX01

ATC

guar gum; oral

2.9

79.0

446

817

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4.3

79.0

257

317

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

9.7

78.8

131

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

3.3

78.7

367

596

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.0

78.7

413

724

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023520) Reticulocytes [#/volume] in Blood

2752

6332

2.39

319.56

3.1

2.8

72.34

67.36

e9/l

6.95

2049

4586

(40758558) Short blood count panel - Blood

10056

36203

1.62

315.01

7.7

6.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3076

5471

3.14

307.65

5.8

2.3

92.41

59.41

ng/l

47.74

2794

4806

(40760892) CBC W Ordered Manual Differential panel - Blood

19231

70944

1.80

307.65

7.6

5.9

—

(3000991) Gas panel - Venous blood

3531

7106

2.78

307.65

11.7

6.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3509

7407

2.65

307.65

9.0

5.8

1.35

1.31

mmol/l

1.05

3427

7217

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5915

16028

2.11

307.65

1.9

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

20808

78761

1.79

307.65

7.2

5.4

2.03

1.96

e9/l

3.70

18863

70859

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4112

10148

2.27

307.65

1.8

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5052

11795

2.44

307.65

2.2

369.28

385.69

nmol/l

6.00

4669

10943

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

11428

29242

2.47

307.65

2.4

1.8

213.12

216.50

u/l

0.09

10849

27607

(3018095) Leukocytes [#/volume] in Urine

13258

47622

1.69

307.65

4.5

2.8

62.53

77.43

e6/l

1.57

9529

30481

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7622

22726

1.95

307.65

1.6

1.5

36812857.49

36027320.50

pmol/l

0.03

6563

19491

(3013115) Eosinophils [#/volume] in Blood

20884

78224

1.82

307.65

7.7

5.7

0.19

0.18

e9/l

6.61

18761

69652

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2708

5673

2.64

307.65

5.6

3.2

5.10

5.12

kpa

0.62

2603

5387

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5564

11402

2.83

307.65

9.4

3.9

1.08

1.05

mmol/l

11.09

5275

10626

(3033658) Prothrombin time (PT) actual/Normal

10004

32551

1.82

307.65

4.8

3.1

94.62

95.43

2.47

9700

31689

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

9862

29941

1.97

307.65

2.3

2.0

2.81

2.63

mg/l

10.76

8591

25500

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

8677

14494

3.74

307.65

3.4

1.7

1142.29

383.26

ng/l

37.71

7155

11027

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

18367

55609

2.33

307.65

8.3

4.6

1.21

1.22

mmol/l

22.58

15771

47072

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

897

905

5.35

307.65

1.3

0.28

0.41

nmol/l

0.37

(3006504) Eosinophils/100 leukocytes in Blood

18809

71747

1.70

307.65

7.3

5.5

2.74

2.86

10.38

17808

67518

(3020682) Albumin/Creatinine [Ratio] in Urine

11735

16322

4.90

307.65

4.4

3.3

14.42

6.82

mg/mmol

6.07

7985

9769

(3009343) pH of Capillary blood

2679

5624

2.63

307.65

5.6

3.2

7.41

7.42

9.00

399

588

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6116

14104

2.52

307.65

3.1

2.0

29.70

29.15

10.13

5926

13641

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

39084

179503

3.16

307.65

11.2

7.0

29.10

25.43

u/l

148.07

38232

173346

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5604

12546

2.58

307.65

3.2

1.7

23.57

25.07

9.31

4884

10861

(3035350) Ketones [Presence] in Urine by Test strip

19262

74452

1.68

307.65

3.8

2.7

0.00

estimate

0.03

4089

14682

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2290

4471

2.81

307.65

11.3

8.1

0.68

0.70

1.25

2275

4442

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

33621

129767

2.86

307.65

5.6

3.1

39.42

36.47

mmol/mol

307.65

31931

121386

(3037467) Urinalysis macro (dipstick) panel - Urine

25848

105684

1.77

307.65

4.6

3.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

16330

59116

1.76

307.65

2.7

2.1

71.68

1569.69

nmol/l

0.50

15218

54855

(3013826) Glucose [Moles/volume] in Serum or Plasma

22610

73349

2.37

307.65

5.6

3.3

6.63

6.14

mmol/l

159.91

21180

65746

(3000963) Hemoglobin [Mass/volume] in Blood

40234

199885

2.52

307.65

22.9

12.1

137.05

136.96

g/l

0.56

39926

197211

(3000850) Epithelial cells [#/volume] in Urine

8102

24982

1.89

307.65

3.2

2.0

6.59

6.93

e6/l

0.95

7397

21976

(40768446) Kidney Pathology biopsy report

446

101

23.64

307.65

2.0

1.1

—

(3013512) EKG study

9973

27987

2.16

307.65

3.3

2.2

—

(3022096) Basophils/100 leukocytes in Blood

18218

69134

1.70

307.65

7.3

5.6

0.66

0.69

8.03

17180

64763

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7156

16746

2.52

307.65

3.7

2.1

566.38

199.99

ng/l

8.55

4573

8607

(3026782) Osmolality of Urine

7511

23761

1.82

307.65

3.3

2.2

537.73

561.76

mosm/kgh2o

9.83

6587

20151

(3010813) Leukocytes [#/volume] in Blood

40231

199794

2.53

307.65

22.8

12.1

6.93

6.49

e9/l

220.36

39560

193806

(3009508) Creatinine [Moles/volume] in Urine

13580

24020

3.95

307.65

4.0

2.7

8.17

9.22

mmol/l

1.12

12020

21157

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

870

617

7.61

307.65

1.5

1.3

539.95

392.22

pmol/l

0.60

771

552

(3002030) Lymphocytes/100 leukocytes in Blood

19499

75828

1.68

307.65

7.3

5.5

29.07

30.36

53.27

18562

71758

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

10216

31724

1.93

307.65

1.7

1.5

1.53

1.25

mmol/l

109.51

8825

27864

(3026008) Bacteria identified in Urine by Culture

10378

37125

1.64

307.65

2.8

2.2

—

(3019069) Monocytes/100 leukocytes in Blood

18926

72156

1.71

307.65

7.6

5.8

8.17

8.21

0.84

17962

68030

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

897

910

5.32

307.65

1.3

0.52

0.50

nmol/l

0.71

863

881

(3018010) Neutrophils/100 leukocytes in Blood

19208

74722

1.67

307.65

7.1

5.3

56.77

55.39

52.13

18264

70703

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4178

10294

2.28

307.65

1.9

1.5

—

(3019060) Gas panel - Arterial blood

2237

4371

2.81

307.65

5.3

4.0

—

(3044889) 12 lead EKG panel

27396

86194

2.96

307.65

3.5

2.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

22664

87588

1.80

307.65

11.0

8.1

4.17

3.80

e9/l

104.50

20150

76771

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

31240

124641

2.27

307.65

4.7

3.5

14.60

14.34

pmol/l

62.57

29393

114449

(3002582) Erythrocytes [#/volume] in Urine

11270

37835

1.79

307.65

3.9

2.4

80.15

75.76

e6/l

0.10

8823

27774

(3015377) Calcium [Moles/volume] in Serum or Plasma

12464

40346

1.91

307.65

3.1

3.2

2.35

mmol/l

0.11

11345

36250

(3015736) pH of Urine

16182

60331

1.68

307.65

3.6

2.5

5.89

5.97

2.68

1568

6686

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4088

10757

2.12

307.65

4.4

4.5

234.59

234.30

u/l

0.04

3881

10249

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

9960

29111

2.07

307.65

2.2

1.6

0.96

1.02

mg/l

1.01

7357

20926

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2821

4456

3.52

307.65

2.3

1.6

7.25

4.89

ug/l

5.75

2521

3743

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

19544

65283

2.10

307.65

6.1

5.4

10.39

10.77

umol/l

3.98

18489

61356

(3006315) Basophils [#/volume] in Blood

20234

75323

1.82

307.65

7.2

5.5

0.04

e9/l

21.36

17903

66159

(3003396) Base excess in Arterial blood by calculation

4012

8485

2.66

307.65

9.0

6.1

0.77

0.86

mmol/l

0.64

3134

6506

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1804

3212

3.07

307.65

4.2

2.6

0.65

0.68

2.14

1792

3199

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1747

2816

3.39

307.65

8.5

4.2

1.43

1.04

mg/l

78.24

1677

2652

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2243

4366

2.82

307.65

7.4

5.4

24.30

24.43

mmol/l

0.72

2136

4090

(3026361) Erythrocytes [#/volume] in Blood

40229

199750

2.53

307.65

22.8

12.0

4.58

4.57

e12/l

5.64

39564

193832

(3021601) Nitrite [Presence] in Urine by Test strip

19223

74673

1.67

307.65

5.2

3.7

0.00

estimate

1.85

4017

14419

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

35251

149070

2.56

307.65

12.4

7.1

91.50

93.59

ml/min/173m2

52.88

29596

117174

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1048

994

5.70

307.65

2.6

2.2

184.22

20.95

ug/min

12.12

708

579

(3042936) Bacteria identified in Isolate by Culture

5539

16338

1.92

307.65

2.2

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

10112

27967

2.21

307.65

2.7

1.9

2446.36

3323.25

umol/l

1.90

9190

25247

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6631

15398

2.52

307.65

5.0

3.4

0.82

0.83

mmol/l

12.07

6284

14471

(3021960) Folate [Moles/volume] in Serum or Plasma

7931

23268

1.99

307.65

1.6

1.4

19.59

20.66

nmol/l

8.42

7076

20353

(3012544) pH of Venous blood

3943

7684

2.90

307.65

6.2

3.1

7.37

7.39

1.34

(3030467) Casts [#/volume] in Urine by Automated count

10328

34065

1.80

307.65

3.8

2.3

0.33

0.28

e6/l

1.50

8000

24534

(3024731) MCV [Entitic volume]

40226

199707

2.53

307.65

22.7

12.0

89.99

89.92

2.58

39925

197017

(3023368) Bacteria identified in Blood by Culture

9329

26889

2.08

307.65

4.5

3.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2697

4091

3.66

307.65

3.3

1.8

149.95

71.73

ng/l

15.43

2395

3508

(3026250) Tacrolimus [Mass/volume] in Blood

546

113

25.93

307.65

40.5

28.8

7.43

7.36

ug/l

0.10

518

(40761511) CBC panel - Blood by Automated count

38386

181163

2.40

307.65

13.8

7.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

19375

76704

1.63

307.65

3.4

2.6

101.45

83.10

ug/l

17.02

18375

72519

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

35131

147546

2.59

307.65

4.4

2.8

5.92

5.48

mmol/l

307.65

33032

136992

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

7373

23686

1.79

307.65

2.1

1.6

1.46

1.32

49.65

6640

21606

(3019309) Folate [Moles/volume] in Red Blood Cells

5895

16634

2.02

307.65

1.7

1.6

1183.67

1140.35

nmol/l

2.81

4684

12599

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3846

7555

2.87

307.65

6.3

3.1

5.85

kpa

0.10

3715

7312

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3402

6826

2.79

307.65

9.7

6.8

123.79

124.40

g/l

0.76

3313

6599

(3027801) Oxygen [Partial pressure] in Arterial blood

4002

8456

2.67

307.65

9.0

6.1

12.62

14.52

kpa

59.43

3834

8047

(3020564) Creatinine [Moles/volume] in Serum or Plasma

39260

176806

3.64

307.65

16.1

8.3

74.56

69.80

umol/l

127.31

39254

176702

(3020779) Urea [Moles/volume] in Serum or Plasma

3874

5978

3.68

307.65

12.2

4.0

8.48

5.90

mmol/l

101.84

3752

5711

(3023103) Potassium [Moles/volume] in Serum or Plasma

38623

157358

4.66

307.65

15.9

7.4

3.94

3.92

mmol/l

28.73

37927

151242

(3027945) Reticulocytes/100 erythrocytes in Blood

3746

9420

2.22

307.65

3.4

2.8

1.76

1.58

18.32

3393

8413

(3024354) Oxygen [Partial pressure] in Venous blood

3151

6381

2.75

307.65

5.7

3.1

4.89

4.71

kpa

3.86

3032

6171

(3019550) Sodium [Moles/volume] in Serum or Plasma

38445

156891

4.46

307.65

15.8

7.4

139.56

139.71

mmol/l

32.93

37780

151353

(3004119) Hemoglobin [Mass/volume] in Venous blood

2345

4266

3.03

307.65

4.5

2.7

130.49

134.47

g/l

10.98

2284

4184

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

35906

156223

2.49

307.65

4.3

2.9

1.38

1.53

mmol/l

307.65

34140

147662

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

27747

118058

1.72

307.65

3.7

2.4

45.60

33.70

u/l

113.01

26503

112550

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

36435

158723

2.62

307.65

4.7

3.0

2.81

3.00

mmol/l

281.13

34587

149133

(3002385) Erythrocyte distribution width [Ratio]

32819

151845

1.66

307.65

18.2

10.1

14.66

14.54

0.23

32384

148762

(3022948) Iron [Moles/volume] in Serum or Plasma

6525

15848

2.40

307.65

3.1

1.7

13.82

15.10

umol/l

28.95

6156

14832

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2598

5480

2.61

307.65

5.6

3.2

1.29

1.37

mmol/l

0.43

1879

3882

(3024561) Albumin [Mass/volume] in Serum or Plasma

16177

49465

2.19

307.65

5.7

4.1

36.61

36.89

g/l

7.37

15213

45897

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6046

14076

2.49

307.65

3.1

1.7

2.41

2.46

g/l

6.50

5643

12978

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

13669

35973

2.50

307.65

3.2

1.9

41.93

28.69

ng/l

0.98

7395

15740

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4002

8460

2.67

307.65

9.0

6.1

5.06

kpa

0.07

3835

8043

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

12630

39811

1.97

307.65

3.0

2.2

62.40

62.52

u/l

0.01

11792

36766

(3037522) Nuclear Ab [Titer] in Serum

6696

20825

1.84

307.65

1.4

546.30

523.42

titre

0.36

1258

3835

(3014007) Fractional oxyhemoglobin in Arterial blood

2293

4470

2.82

307.65

11.4

8.2

93.76

94.83

9.76

2279

4457

(3013707) Erythrocyte sedimentation rate by Westergren method

27895

111941

1.95

307.65

4.3

3.3

10.48

8.52

mm/h

118.18

26319

104222

(3009261) Glucose [Presence] in Urine by Test strip

19376

75319

1.67

307.65

3.9

2.7

0.01

0.00

estimate

1.11

3838

14242

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13922

45293

1.94

307.65

1.9

1.6

97.73

98.24

pmol/l

0.57

7712

23932

(3018418) pH of Serum or Plasma

11227

31580

2.21

307.65

4.9

2.9

7.40

2.08

2284

5845

(3031040) Bacteria [#/volume] in Urine by Automated count

24145

100526

1.64

307.65

4.6

3.3

1686.73

1285.15

e6/l

0.42

369

1181

(3007461) Platelets [#/volume] in Blood

40213

199370

2.56

307.65

22.8

12.1

264.31

257.21

e9/l

87.68

39629

193832

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1845

3281

3.07

307.65

4.3

2.6

1.40

1.38

0.20

1832

3264

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

15191

58590

1.59

307.65

3.8

2.7

—

(3035941) MCH [Entitic mass]

40226

199677

2.54

307.65

22.7

12.0

30.07

30.08

0.34

39924

197007

(3001604) Monocytes [#/volume] in Blood

20199

75185

1.82

307.65

7.2

5.5

0.57

0.53

e9/l

74.69

17895

66140

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2294

4462

2.82

307.65

11.2

8.1

1.45

1.35

3.29

2281

4428

(3011985) Renin [Units/volume] in Plasma

918

742

6.68

307.65

1.7

2.1

64.61

52.64

mu/l

0.42

836

690

(3009542) Hematocrit [Volume Fraction] of Blood

40183

199085

2.55

307.65

23.0

12.0

40.82

41.05

0.83

38385

189121

(3012516) Albumin [Mass/volume] in Urine

11242

15669

4.82

307.65

3.7

2.8

345.04

825.94

mg/l

10.94

7698

9181

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14825

47336

2.02

307.65

3.6

2.9

31.59

30.69

u/l

0.84

14155

45127

(3002032) Base excess in Venous blood by calculation

3820

7508

2.87

307.65

6.4

3.1

1.55

1.88

mmol/l

5.44

3224

6266

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

34818

149530

2.36

307.65

4.0

2.7

1.40

1.16

mmol/l

307.65

32952

140773

(3016502) Oxygen saturation in Arterial blood

3614

7257

2.79

307.65

9.5

6.6

95.86

96.68

9.25

3480

6933

(3022217) INR in Platelet poor plasma by Coagulation assay

15829

44527

2.42

307.65

11.2

4.5

1.16

1.07

inr

43.54

5108

14214

(3042733) HLA Ab [Presence] in Serum

389

25.37

307.65

4.8

2.9

—

(3021589) Normoblasts [#/volume] in Blood

17588

68449

1.62

307.65

10.4

7.3

0.00

e9/l

0.86

14527

55983

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

16631

49903

2.27

307.65

7.8

4.2

1.21

1.22

mmol/l

22.71

15448

45460

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

37046

169631

2.32

307.65

14.8

8.4

19.93

21.64

mg/l

18.61

30392

123230

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

36108

157338

2.52

307.65

4.4

2.9

4.66

4.91

mmol/l

307.65

34444

148783

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2337

4442

2.89

307.65

7.1

3.6

23.97

24.23

mmol/l

3.46

2288

4367

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

28639

107738

2.28

307.65

7.9

6.1

75.84

74.32

u/l

7.55

27278

101419

(36304419) Bacteria [Presence] in Urine

10247

34282

1.77

307.65

3.7

2.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

35587

148246

2.77

307.65

5.4

4.0

1.85

2.10

mu/l

2.32

33788

138373

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1169

1639

3.86

307.43

5.9

3.2

0.33

0.35

u/ml

0.97

640

848

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6262

19916

1.78

307.41

3.2

2.1

1.03

1.15

e6/l

0.31

3575

10330

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1707

3106

2.99

307.35

2.1

1.8

1.43

1.30

g/l

4.95

1485

2674

(3029937) Albumin [Presence] in Urine by Test strip

10591

38849

1.59

305.80

4.2

2.9

0.01

0.00

estimate

1.47

3869

14129

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

800

815

5.28

300.52

1.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

852

933

4.92

297.73

20.8

18.9

1449.33

2334.49

nmol/l

0.41

831

891

(3027456) Digoxin [Moles/volume] in Serum or Plasma

365

101

19.31

296.72

2.9

2.8

0.82

0.86

nmol/l

0.22

279

(3007853) Bacteria identified in Skin by Aerobe culture

5068

15244

1.87

296.24

1.8

1.5

—

(3019150) Specific gravity of Urine by Refractometry

8986

31894

1.63

294.76

4.1

2.8

1.02

kg/l

0.17

1187

4891

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2664

6272

2.34

293.59

11.3

5.9

24.53

24.75

mmol/l

2.36

2648

6216

(3020891) Body temperature

1518

2643

3.12

293.26

5.3

3.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1735

3284

2.88

292.11

4.7

2.4

24.90

25.41

mmol/l

6.97

1666

3177

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3510

9305

2.09

291.87

3.8

3.1

4.65

4.62

pmol/l

0.77

3177

8337

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4815

14347

1.88

289.15

3.4

2.5

6.69

7.57

umol/l

2.33

4076

12252

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2005

4152

2.64

286.94

12.3

7.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

818

893

4.93

286.72

15.5

12.7

1508.10

771.13

nmol/l

0.59

796

865

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6024

19402

1.75

281.09

2.6

2.9

2.43

2.42

mmol/l

2.10

5263

17008

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

273

60.67

280.02

7.0

4.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4369

12730

1.91

279.85

6.2

3.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3723

10344

2.00

272.51

2.7

2.6

10.29

10.55

g/l

3.10

3427

9453

(3011397) Hemoglobin [Presence] in Urine by Test strip

8971

32380

1.60

271.51

3.9

2.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3206

8442

2.10

270.36

2.8

2.1

72.15

83.64

ml/min/173m2

33.04

1261

2733

(3020630) Protein [Mass/volume] in Serum or Plasma

2553

6152

2.28

266.36

2.3

2.5

66.75

67.42

g/l

3.66

2372

5658

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3596

10045

1.98

258.70

2.7

2.4

0.22

g/l

0.18

3377

9440

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1152

1832

3.40

254.86

4.7

2.5

23.95

24.53

mmol/l

4.62

1132

1784

(3024928) Oxygen saturation in Venous blood

989

1418

3.76

252.35

4.5

3.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1582

3098

2.77

250.38

4.9

2.8

52.51

48.25

7.00

1557

3064

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

17225

72317

1.44

250.27

2.7

2.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1848

3936

2.56

249.88

2.1

1.7

1.18

1.14

g/l

7.73

1772

3751

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3096

8312

2.05

247.44

4.5

2.9

1.23

mmol/l

1.06

2721

7153

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1793

3794

2.57

245.48

2.1

1.7

0.23

0.22

g/l

8.65

1717

3603

(3044640) Blood type and Crossmatch panel - Blood

11525

44957

1.49

241.17

2.5

2.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5835

19385

1.69

240.56

3.4

2.2

3.66

3.36

e6/l

0.93

3155

9839

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

10964

42366

1.50

239.84

1.4

1.3

1.58

1.83

u/ml

1.12

3192

11735

(3022313) Gas panel - Capillary blood

1883

4147

2.47

237.89

6.3

3.4

—

(3028707) Methadone [Presence] in Urine by Screen method

2144

5023

2.33

237.54

4.0

2.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

1276

2272

3.04

237.31

4.0

3.4

1.38

1.39

mmol/l

0.13

1257

2224

(40768797) Stomach Pathology biopsy report

5187

16806

1.73

233.38

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1832

4023

2.48

232.73

12.5

8.1

24.05

24.31

mmol/l

2.58

1782

3918

(3010375) cycloSPORINE [Mass/volume] in Blood

403

237

9.09

232.23

29.8

19.1

121.59

140.25

ug/l

1.49

338

210

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7518

26997

1.58

226.75

1.3

27.75

30.76

iu/ml

0.35

2284

8534

(40761535) Cells panel - Urine sediment

3045

8405

1.99

225.06

3.8

2.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

9501

36028

1.51

224.49

1.5

1.4

2.25

2.14

g/l

7.32

6194

22574

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1406

2766

2.75

220.36

2.8

1.9

617.32

351.72

ug/l

0.77

1288

2449

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1022

1654

3.33

220.18

5.7

2.2

910.52

14864.41

u/ml

1.16

104

(3041096) Erythrocytes [Presence] in Urine by Automated

11166

44000

1.47

217.56

3.3

2.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1897

4392

2.35

215.27

1.7

1.5

16.46

8.62

u/ml

1.24

144

(3028026) IgM [Mass/volume] in Serum or Plasma

2857

7830

2.00

214.98

1.7

1.9

1.25

1.35

g/l

1.81

2660

7209

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3616

10751

1.86

214.86

3.3

2.5

—

(1616796) Gas panel - Central venous blood

1074

1843

3.14

211.65

4.5

2.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7060

25416

1.57

208.54

1.3

7.31

10.60

u/ml

4.99

2943

10364

(3004588) Protein electrophoresis panel - Serum or Plasma

1946

4628

2.29

207.94

2.0

2.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

1099

1938

3.06

207.40

4.2

3.5

3.86

3.80

mmol/l

4.01

1090

1915

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1243

2369

2.83

205.95

8.5

3.2

604.85

542.55

iu/ml

0.15

200

198

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2743

7524

2.00

205.60

1.7

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8799

33428

1.50

202.74

2.5

1.9

—

(3021901) Oxygen saturation in Capillary blood

839

1255

3.59

202.08

3.7

2.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2007

4992

2.19

192.94

1.6

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

380

280

7.25

188.00

1.4

1.3

162.73

147.61

mmol/24h

1.60

380

280

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1020

1833

3.00

186.55

3.9

1.7

0.94

0.68

nmol/l

18.63

865

1578

(3010421) pH of Blood

1193

2352

2.74

185.96

4.8

2.4

7.41

7.42

3.04

1072

2167

(3017181) Myelocytes/100 leukocytes in Blood

3472

10685

1.79

183.44

4.8

4.1

0.81

0.94

1.78

1184

3038

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3844

12202

1.74

182.86

2.9

2.2

50.25

41.30

u/l

0.31

3294

10590

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

189

38.69

181.94

6.0

5.3

2.37

2.11

mg/l

0.26

165

(3024932) HLA-DR beta [Type]

322

198

8.68

180.47

1.1

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

928

1615

3.09

178.72

4.8

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1667

3956

2.28

178.52

6.3

3.4

24.49

24.60

mmol/l

0.85

1590

3739

(3036489) Thrombin time

1997

5121

2.12

177.86

3.1

2.0

21.26

20.75

3.22

1710

4287

(3024471) HLA-A [Type]

324

210

8.23

175.46

1.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1237

2575

2.59

174.09

7.5

3.7

9.13

9.14

kpa

0.03

1212

2499

(3020876) Protein [Mass/time] in 24 hour Urine

482

514

5.02

172.94

2.9

2.6

1.87

0.96

g/24h

4.62

294

219

(3023183) Ammonium ion [Moles/volume] in Plasma

935

1678

3.00

171.31

3.3

2.4

34.29

33.42

umol/l

0.44

870

1546

(3002179) Metamyelocytes/100 leukocytes in Blood

3197

9804

1.79

170.32

4.4

3.9

0.56

0.67

1.55

1036

2667

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2279

6266

1.98

168.74

1.6

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1362

3032

2.43

167.46

6.0

4.0

0.90

0.95

2.12

1267

2808

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1257

2692

2.52

167.26

2.2

1.8

2.14

2.22

ug/l

0.04

1130

2374

(3021440) Promyelocytes/100 leukocytes in Blood

3302

10284

1.76

166.91

4.9

4.2

0.08

0.13

3.93

1016

2645

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1372

3110

2.38

162.31

5.9

3.9

1.81

1.75

0.91

1274

2877

(3025159) Blasts/100 leukocytes in Blood

3170

9832

1.77

162.30

4.9

4.2

0.26

0.28

0.07

873

2217

(3037121) Protein [Mass/volume] in Urine

1551

3717

2.26

162.21

4.7

2.8

0.46

0.21

g/l

7.16

865

1628

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1380

3141

2.37

161.83

1.5

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1494

3526

2.29

161.78

2.3

1.8

4.73

19.28

iu/l

0.47

632

1310

(3027315) Oxygen [Partial pressure] in Blood

1027

2032

2.72

158.89

4.7

2.5

9.11

9.15

kpa

0.24

1011

1980

(3013290) Carbon dioxide [Partial pressure] in Blood

1023

2028

2.72

157.71

4.7

2.5

5.00

kpa

0.06

1007

1976

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1674

4193

2.16

157.66

4.1

2.4

3.56

3.52

g/l

0.57

1590

3972

(3012501) Base excess in Blood by calculation

1022

2028

2.71

157.27

4.7

2.5

2.14

2.20

mmol/l

0.24

646

1258

(1002224) Polysomnography panel

2368

6760

1.91

157.20

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1771

4650

2.06

147.99

4.1

2.2

95.12

95.03

0.05

1707

4444

(40767503) Oxygen content in Capillary blood by calculation

918

1776

2.78

147.85

2.8

1.8

17.18

17.49

1.20

529

775

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1517

3750

2.19

147.35

1.7

1.6

360.67

317.72

titre

0.17

136

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1412

3391

2.25

146.79

1.9

1.3

—

(1761868) Lipid panel - Serum or Plasma

15012

65462

1.33

146.77

2.7

2.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1937

5277

1.99

146.63

2.0

1.9

38.46

41.17

u/l

6.75

1745

5041

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1408

3387

2.24

145.80

1.8

1.2

19.43

21.35

u/ml

0.18

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1645

4254

2.09

142.88

3.5

2.4

176.09

162.72

7.96

1571

4010

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1339

3181

2.27

142.66

1.9

1.2

105.90

105.09

u/ml

0.07

273

681

(3047181) Lactate [Moles/volume] in Blood

1243

2857

2.35

142.54

6.4

4.0

1.27

1.21

mmol/l

1.49

1083

2502

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

821

1533

2.87

140.66

2.9

3.8

1.98

3.23

ratio

0.57

141

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

839

1587

2.84

140.57

3.0

3.8

42.48

26.37

mg/l

1.44

668

1304

(3034860) Kappa light chains.free [Mass/volume] in Serum

839

1592

2.83

139.80

3.0

3.8

62.01

39.47

mg/l

1.50

667

1306

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

660

1081

3.27

139.52

1.2

25.79

31.55

nmol/l

0.31

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2029

5758

1.91

136.59

1.3

1.2

0.92

0.98

u/ml

0.08

185

403

(4094501) Cardiovascular stress test using bicycle ergometer

1018

2171

2.52

136.42

1.1

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

6893

26726

1.44

135.61

1.8

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1421

3548

2.16

134.59

1.6

1.2

250.26

229.80

u/ml

1.88

952

2203

(3011288) Drugs identified in Urine by Screen method

2820

8920

1.72

133.93

4.6

2.5

—

(3004775) Volume in Urine collected for unspecified duration

336

323

5.55

133.37

2.5

2.0

665.91

608.07

1.20

252

244

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1639

4348

2.04

133.08

2.2

1.7

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

640

1063

3.22

132.47

12.5

11.4

0.60

0.61

mmol/l

0.18

585

984

(3009466) Valproate [Moles/volume] in Serum or Plasma

931

1926

2.60

132.40

5.8

5.1

368.18

380.86

umol/l

1.48

820

1669

(3000034) Microalbumin [Mass/volume] in Urine

425

518

4.38

132.18

3.2

2.7

108.93

51.57

mg/l

1.66

329

332

(3019225) pH of Specimen

3239

10681

1.66

132.01

4.4

3.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1478

3802

2.10

129.95

1.6

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

961

2044

2.53

129.44

1.1

81.92

4606.94

iu/ml

0.64

240

592

(3003338) MCHC [Mass/volume]

32467

159262

1.35

128.09

19.3

10.1

333.45

333.53

g/l

0.80

32293

157864

(3048689) Calprotectin [Mass/mass] in Stool

6217

23882

1.45

127.64

2.4

2.7

110.60

121.78

ug/g

1.85

4978

18923

(3034770) Mitochondria Ab [Titer] in Serum

1392

3536

2.12

126.28

1.3

1272.26

853.73

titre

0.76

102

(3011648) Oxygen content in Venous blood

434

562

4.12

125.77

4.7

5.6

11.25

11.42

0.30

434

562

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1024

2295

2.40

123.86

1.8

1.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

451

614

3.92

122.91

1.4

1.5

1.47

1.25

nmol/l

3.06

405

568

(3052851) Hemolysis interference index of Serum or Plasma

1291

3227

2.16

121.83

3.0

2.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

1416

3673

2.08

121.78

1.3

81.96

135.03

titre

1.89

138

350

(4200892) Spirometry reversibility

2613

8324

1.71

120.58

1.4

1.3

—

(3003181) Sodium [Moles/volume] in Urine

578

958

3.23

120.03

1.5

1.8

66.40

73.80

mmol/l

2.27

476

741

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1271

3183

2.15

119.37

2.1

1.9

11.19

9.67

mg/l

4.64

1194

3004

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

556

906

3.28

118.46

7.9

5.6

10.81

9.91

mg/l

3.70

518

834

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1032

2374

2.34

117.99

1.8

1.6

—

(3016750) Collection duration of Urine

283

260

5.80

117.10

2.5

1.8

505.51

510.35

min

0.29

225

210

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

5182

19519

1.46

116.82

1.7

2.0

—

(3000494) Fungus identified in Specimen by Culture

4400

16035

1.51

116.63

1.6

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

646

1170

2.96

116.52

3.0

4.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

593

1027

3.09

115.04

1.2

1.3

34.33

41.84

u/l

0.41

519

900

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

742

1477

2.69

113.43

1.4

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

3066

10379

1.61

111.96

3.4

1.9

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1177

2938

2.16

111.37

1.5

1.4

12.63

9.65

iu/ml

0.33

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1000

2351

2.28

108.90

1.4

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

548

939

3.12

108.13

1.5

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1082

2641

2.20

108.04

2.0

2.1

3.66

3.64

g/l

0.15

1005

2407

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1082

2643

2.20

107.84

2.0

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1082

2646

2.20

107.55

2.0

2.1

7.30

6.97

g/l

7.24

1004

2409

(3039000) Anion gap in Blood

820

1780

2.47

105.96

8.0

5.3

11.38

11.17

mmol/l

0.85

731

1578

(3018572) Chloride [Moles/volume] in Blood

820

1781

2.47

105.84

8.0

5.3

105.28

105.64

mmol/l

1.08

731

1579

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1938

5875

1.78

105.71

3.2

2.1

0.28

0.25

e6/l

0.42

1865

5689

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1156

2935

2.12

104.85

1.8

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3892

14123

1.51

104.56

1.3

1.2

141.61

151.11

iu/ml

0.61

1493

5371

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

539

952

3.03

101.35

1.1

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

356

470

4.04

100.86

1.6

3.81

2.20

nmol/l

0.88

293

371

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1032

2542

2.18

100.80

2.1

2.92

2.81

g/l

2.36

955

2305

(3036180) Methadone [Presence] in Urine

634

1237

2.74

100.54

3.6

2.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2385

7780

1.66

100.30

1.5

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7206

29470

1.36

99.95

3.9

2.17

2.78

ug/l

2.14

6531

26987

(3005322) IgE [Units/volume] in Serum or Plasma

3301

11679

1.54

99.37

1.3

233.43

255.47

u/ml

0.40

3071

10826

(3012565) Volume of 24 hour Urine

300

346

4.62

99.31

2.1

2.4

1963.31

2140.39

1.41

281

323

(3042517) Benzodiazepines panel - Urine

237

217

5.82

98.44

3.1

2.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

993

2447

2.18

96.88

2.1

10.15

10.44

g/l

1.03

912

2197

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1155

3028

2.05

96.45

1.4

1.3

293.38

302.44

ug/g

0.64

620

1606

(3006184) Hemoglobin [Mass/volume] in Capillary blood

922

2209

2.24

96.13

2.4

1.8

133.03

134.35

g/l

0.83

729

1612

(3028271) Lactate [Moles/volume] in Capillary blood

682

1419

2.57

95.90

2.1

1.5

1.68

1.76

mmol/l

1.12

670

1385

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

828

1905

2.33

94.59

1.3

1.2

247.14

138.82

titre

0.25

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

749

1651

2.43

93.77

1.8

1.7

—

(40761536) Microorganisms panel - Urine sediment

3633

13288

1.49

93.38

4.1

2.9

—

(3035637) Corticotropin [Mass/volume] in Plasma

739

1639

2.41

91.34

1.8

1.5

—

(3016879) Cocaine [Presence] in Urine

3467

12615

1.50

91.28

3.3

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

924

2271

2.18

90.70

2.1

2.2

0.52

0.82

g/l

1.67

829

1999

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

855

2034

2.25

90.61

2.0

0.01

0.02

g/l

0.61

792

1888

(4146454) Self-monitoring of blood glucose

356

514

3.69

90.03

2.7

2.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

624

1286

2.60

89.39

1.8

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1414

4107

1.85

88.18

1.3

28.06

36.51

u/ml

0.57

249

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

791

1846

2.30

87.55

2.0

0.00

g/l

0.75

731

1701

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

733

1654

2.37

87.35

1.6

1.3

—

(36660697) Celiac disease serology panel - Serum

4015

15170

1.45

87.22

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

784

1826

2.30

87.17

2.0

0.00

g/l

-0.00

729

1699

(40757494) Bilirubin.total [Moles/volume] in Blood

261

300

4.63

86.78

2.4

2.0

22.04

45.43

umol/l

1.33

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

847

2056

2.21

85.64

2.0

38.33

39.62

g/l

6.29

769

1812

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

106

18.77

85.63

5.5

3.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

360

549

3.50

84.53

2.9

2.3

176.77

154.67

umol/l

0.43

188

281

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

753

1747

2.31

84.45

1.8

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

753

1749

2.31

84.24

1.8

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1305

3751

1.87

83.99

1.3

12.60

9.72

u/ml

0.50

191

564

(3000764) Benzodiazepines [Presence] in Urine

3647

13665

1.45

82.51

3.3

1.8

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

103

18.24

82.41

5.3

3.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2944

22325

0.68

82.30

1.4

1.5

—

(40768804) Tissue Pathology biopsy report

13966

63631

1.24

81.87

2.0

1.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1282

3695

1.87

81.81

1.3

10.28

7.96

u/ml

0.26

127

379

(3028300) Cannabinoids [Presence] in Urine

3668

13802

1.45

81.09

3.3

1.8

—

(3027008) Opiates [Presence] in Urine

3656

13767

1.45

80.48

3.1

1.8

—

(3022145) Colonoscopy Study observation

4062

15613

1.42

79.99

1.3

1.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

24.16

79.22

7.2

2.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

190

174

5.81

78.99

7.8

3.8

326.16

22.85

g/mol

0.68

180

157

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

470

888

2.83

78.99

3.3

1.9

97.19

98.98

0.48

442

805

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

670

1529

2.34

77.94

1.7

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

226

253

4.75

77.35

3.0

2.3

—

(3025941) Bacteria identified in Stool by Culture

2748

9850

1.51

77.14

1.3

1.2

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

563

1188

2.53

77.07

1.8

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

563

1188

2.53

77.07

1.8

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1302

3856

1.81

76.29

1.4

453.39

499.99

mg/l

1.17

1239

3674

(3016650) Hepatitis A virus Ab [Presence] in Serum

1003

2724

1.97

76.08

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

106

93.86

75.84

7.2

11.5

6.40

4.80

mmol/l

—

106

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3839

14743

1.42

75.72

4.1

2.9

30.55

32.25

17.55

2944

10387

(3017732) Neutrophils [#/volume] in Blood

2916

10624

1.49

75.67

2.7

2.2

4.82

4.40

e9/l

0.94

2516

9028

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

142

7.86

74.93

1.3

1.2

399.15

399.07

pmol/l

0.00

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3085

11394

1.47

74.79

2.3

20.88

20.91

au/ml

0.01

264

1184

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2880

10497

1.49

74.55

1.3

52.59

46.12

au/ml

0.54

109

538

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

707

1690

2.24

74.12

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

554

1184

2.50

73.95

1.7

1.4

1.38

1.51

promille

1.06

435

914

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

606

1358

2.38

73.33

1.5

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

554

1190

2.49

73.20

2.0

1.5

91.19

91.15

0.06

546

1168

(3027944) Amphetamines [Presence] in Urine

3561

13585

1.43

72.70

3.1

1.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

174

159

5.82

72.52

7.1

3.6

24.62

24.91

mmol/l

0.28

166

146

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1162

3373

1.85

72.51

1.3

1.4

3.70

3.49

mmol/l

9.15

1091

3154

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1127

3247

1.86

71.96

1.3

1.2

40.67

42.05

u/ml

0.08

111

259

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1014

2823

1.93

71.69

1.2

12.79

20.05

u/ml

0.30

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1034

2905

1.91

71.19

1.3

6.70

3.39

u/ml

0.49

216

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1163

3399

1.84

71.04

1.5

18.17

26.30

e6/l

0.76

884

2626

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1162

3403

1.83

70.53

1.5

1673.63

2112.70

e6/l

0.13

926

2751

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

935

2555

1.96

69.71

1.3

1.2

4.66

3.58

u/ml

1.39

419

1159

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

563

1254

2.40

69.04

1.6

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

338

573

3.14

67.99

1.2

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

595

1370

2.32

67.92

3.4

3.1

27.86

25.55

mu/l

0.64

570

1277

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

506

1079

2.50

67.88

2.0

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

125

8.10

67.37

9.9

5.0

—

(3037756) Immunofixation for Serum or Plasma

539

1190

2.42

67.34

1.5

2.1

—

(3008295) Osmolality of Serum or Plasma

458

933

2.62

67.18

1.6

1.8

284.06

285.64

mosm/kgh2o

0.65

360

753

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3245

12349

1.43

66.89

2.4

2.0

11.19

12.82

nmol/l

21.99

2940

11391

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

512

1110

2.46

66.43

1.5

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

345

606

3.03

65.62

1.2

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

116

8.56

64.84

9.9

5.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

201

238

4.49

64.82

2.1

1.6

141.82

8.30

ug/min

2.27

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

115

8.49

63.93

5.3

3.3

46.34

26.87

ug/min

1.36

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

142

120

6.29

63.34

2.7

2.5

37.47

18.73

mg/l

1.03

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5594

23439

1.31

62.34

3.5

3.3

21.42

20.68

2.40

2168

9322

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

943

2688

1.88

62.19

1.3

1.2

3.71

3.51

u/ml

0.11

323

953

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

783

2095

2.00

61.90

1.2

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

601

1450

2.21

61.72

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2085

7381

1.52

61.65

1.5

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

487

1069

2.43

61.62

5.7

2.8

7.40

6.55

mmol/l

1.98

424

859

(21494890) Protein electrophoresis panel - 24 hour Urine

296

495

3.18

60.87

2.0

2.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

521

1190

2.34

60.58

1.6

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

2785

10495

1.44

60.31

1.7

1.6

342.74

302.82

mu/l

4.56

2529

9349

(3000492) Spirometry study

4153

16747

1.35

60.20

1.4

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

833

2320

1.92

58.84

2.5

2.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

941

2730

1.85

58.81

2.6

2.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

846

2373

1.91

58.54

1.5

1.6

0.69

0.77

g/l

1.20

628

1833

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

456

999

2.43

57.97

1.1

289.77

288.23

mg/l

0.13

413

913

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

462

1025

2.40

57.21

1.7

1.8

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

689

1814

2.03

56.91

1.3

1.2

43.05

44.53

u/ml

0.05

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

909

2641

1.84

56.56

1.1

—

(3016038) Potassium [Moles/volume] in Urine

257

411

3.33

56.55

1.4

2.1

34.29

36.37

mmol/l

0.56

236

376

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

875

2512

1.86

56.49

1.1

116.74

117.15

0.13

810

2266

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1122

3478

1.73

56.39

2.0

1.8

181.42

201.18

pmol/l

6.03

1072

3355

(3027923) C peptide [Moles/volume] in Serum or Plasma

264

431

3.26

56.34

1.8

2.2

1.44

1.20

nmol/l

2.02

212

364

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

448

987

2.42

56.30

3.3

2.8

41448.47

40749.15

ug/l

0.34

448

987

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

805

2257

1.91

55.79

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

805

2259

1.91

55.64

1.3

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

604

1529

2.11

55.23

2.3

2.6

22.54

21.68

nmol/l

0.91

577

1472

(3004451) EKG impression Narrative

163

185

4.68

55.13

1.3

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2034

7336

1.49

54.96

1.1

24.63

11.55

u/ml

0.42

106

(3044290) Cell count panel - Cerebral spinal fluid

1064

3284

1.74

54.28

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1352

4471

1.62

53.40

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

627

1636

2.05

53.06

2.7

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3661

14752

1.35

52.94

2.5

2.4

6606.05

6400.38

u/l

0.12

1239

6219

(3008037) Lactate [Moles/volume] in Venous blood

626

1635

2.04

52.84

3.1

2.2

1.48

1.40

mmol/l

1.01

607

1605

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1470

11764

0.65

52.65

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1471

11756

0.65

52.33

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1464

11701

0.65

52.09

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1596

12531

0.66

52.02

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1470

11733

0.65

51.96

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1354

4511

1.61

51.90

1.2

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1428

4823

1.59

51.75

2.0

1.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4207

17356

1.32

51.70

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

961

2921

1.76

51.67

2.0

2.1

6.38

6.67

titre

0.04

112

(3022689) Creatine [Moles/volume] in Urine

158

186

4.52

51.39

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

1358

4541

1.60

51.28

1.2

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

123

114

5.73

50.76

1.4

1.8

132.31

109.63

mu/l

0.14

(3004809) Band form neutrophils/100 leukocytes in Blood

623

1651

2.01

50.61

3.3

2.9

1.24

1.68

2.37

578

1469

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

658

1782

1.97

50.38

2.4

2.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1987

14881

0.69

50.30

1.4

—

(4034850) Laboratory test

1237

4062

1.63

50.22

9.6

5.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

115

100

6.11

50.17

4.5

2.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

891

2678

1.78

49.75

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

10626

48948

1.20

49.39

1.8

1.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

707

1979

1.91

49.27

2.0

2.1

5.24

5.63

mmol/24h

2.20

641

1799

(3036603) Volume of Urine

305

592

2.74

49.08

1.6

1.7

2103.53

2017.54

0.69

299

587

(3045414) Leukocytes [Presence] in Urine

1705

6071

1.51

48.90

1.9

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

117

107

5.81

48.87

1.1

0.68

11.43

umol/24h

0.49

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1293

4327

1.60

48.66

1.9

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2070

7687

1.45

48.18

1.5

1.4

8.54

8.88

u/l

0.60

1705

6250

(3028192) IgG subclass 2 [Mass/volume] in Serum

572

1499

2.04

47.90

1.4

1.3

2.92

2.99

g/l

0.35

394

1068

(4062490) Immunoglobulin typing, IgG

573

1504

2.03

47.79

1.4

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

571

1498

2.03

47.68

1.4

1.3

6.54

6.78

g/l

0.74

391

1070

(3024139) IgG subclass 3 [Mass/volume] in Serum

571

1498

2.03

47.68

1.4

1.3

0.34

0.40

g/l

3.56

390

1070

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1159

9543

0.63

47.31

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1194

9741

0.64

46.70

1.5

—

(3005033) Fetal Nuchal fold Thickness US

1161

9522

0.64

46.53

1.4

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

237

415

3.04

45.48

8.7

1.6

664.85

5473.38

mg/l

2.11

197

254

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1526

5400

1.52

45.02

2.3

2.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1593

5706

1.50

44.38

1.9

1.6

36.50

42.86

nmol/l

16.90

1555

5633

(3044242) Glucose [Moles/volume] in Arterial blood

181

269

3.58

44.31

2.4

1.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

10.19

44.13

7.1

7.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

328

700

2.49

44.13

1.6

1.4

6.39

5.59

u/l

0.74

282

591

(3008898) HLA-B27 [Presence]

2051

7762

1.42

43.04

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

638

1807

1.88

42.99

1.1

97.17

93.89

2.13

608

1687

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

298

614

2.58

42.98

2.3

2.4

151.93

150.28

nmol/l

0.08

254

526

(3000012) Reticulocyte production index

401

953

2.24

42.81

2.1

2.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

636

1805

1.88

42.60

1.1

1.48

1.43

g/l

2.10

584

1632

(3045716) Anion gap in Serum or Plasma

193

309

3.32

42.54

3.1

1.9

10.00

9.89

mmol/l

0.13

188

294

(3038515) Glucose [Moles/volume] in Venous blood

561

1528

1.96

42.35

3.1

2.2

7.61

6.83

mmol/l

4.73

544

1512

(3020961) Endomysium IgA Ab [Titer] in Serum

2509

9858

1.37

42.27

1.1

223.11

190.35

titre

0.22

301

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

635

1811

1.87

41.92

1.7

1.4

—

(3049717) Cytology report of Urine Cyto stain

886

2811

1.68

41.02

2.4

2.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

477

1239

2.05

40.97

1.5

—

(3022621) pH of Urine by Test strip

2292

8920

1.38

40.89

2.8

2.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

873

2768

1.69

40.52

1.3

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

459

1181

2.07

40.41

1.1

67.45

62.57

u/ml

0.08

(3019977) pH of Arterial blood

202

345

3.11

40.40

2.9

2.4

7.43

0.32

105

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

985

3228

1.63

40.33

1.7

1.6

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

231

429

2.86

40.28

1.5

1.4

14.50

13.29

pmol/l

1.60

197

368

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

302

649

2.48

40.12

1.7

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

3084

12628

1.32

39.45

1.4

20.44

24.15

iu/l

9.21

2631

10769

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

433

1103

2.09

39.13

1.8

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1659

6160

1.44

38.54

1.6

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

408

1023

2.12

38.38

1.2

75.42

70.92

u/l

0.18

378

915

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

485

1301

1.99

38.25

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

344

805

2.28

38.11

1.6

1.7

133.84

118.30

3.59

326

762

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

629

5670

0.58

37.49

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

366

889

2.19

37.21

1.9

1.6

1657797.21

1466995.51

iu/ml

0.12

(3051611) Lipemic interference index of Serum or Plasma

408

1037

2.10

37.11

3.5

2.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

369

905

2.17

36.66

1.2

1.1

—

(3051651) Icteric interference index of Serum or Plasma

291

647

2.39

36.09

3.9

3.2

—

(3023419) Bacteria identified in Sputum by Culture

442

1177

2.00

35.60

2.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1494

11088

0.70

35.49

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

344

831

2.20

35.46

1.5

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

344

831

2.20

35.46

1.5

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

344

831

2.20

35.46

1.5

1.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2608

10588

1.33

35.31

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

286

638

2.39

35.24

1.5

1.3

32.95

39.14

g/l

10.63

252

597

(3017569) Oxygen content in Arterial blood

151

234

3.43

34.99

2.2

2.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

909

3054

1.59

33.71

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2427

9824

1.33

33.50

2.0

1.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

313

745

2.24

33.43

1.1

3.42

3.67

nmol/l

0.03

148

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1371

10188

0.70

32.76

1.7

1.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

269

604

2.37

32.73

1.9

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

543

1600

1.81

32.50

1.2

1.1

34.08

43.41

mg/l

3.65

456

1325

(3045788) Cell count panel - Pleural fluid

226

471

2.55

32.04

1.5

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

274

627

2.32

32.01

1.5

1.4

2836.42

4617.09

e6/l

1.31

184

457

(3042111) Morphology [Interpretation] in Bone marrow Narrative

480

1369

1.87

31.81

1.8

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

295

703

2.23

31.46

2.2

3.6

86.82

95.57

nmol/l

0.26

287

692

(3013005) Retinol [Moles/volume] in Serum or Plasma

321

793

2.15

31.43

2.2

1.98

1.83

umol/l

1.90

301

745

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1375

5123

1.44

31.36

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

787

2600

1.62

31.29

1.5

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

561

1693

1.77

31.07

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

337

854

2.10

30.99

2.4

1.8

4.01

3.98

mmol/l

0.53

331

848

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

524

1551

1.80

30.93

1.1

224.12

246.77

mg/l

1.20

459

1364

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1127

8577

0.69

30.82

1.4

1.5

—

(3035285) Chloride [Moles/volume] in Venous blood

336

854

2.09

30.67

2.4

1.8

105.62

106.02

mmol/l

0.83

330

848

(3011412) CD3 cells [#/volume] in Blood

528

1571

1.79

30.65

2.3

2.7

1.34

1.31

e9/l

0.13

466

1369

(3002256) Pathology report gross observation

4316

18963

1.23

30.63

1.2

—

(3044927) Protein electrophoresis panel - Urine

243

544

2.38

29.81

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

420

1172

1.91

29.75

2.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4010

17536

1.23

29.70

2.6

2.5

0.69

0.71

ug/l

0.61

2347

9620

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1478

5641

1.40

29.50

1.4

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1023

3639

1.50

29.49

1.4

1.3

18.91

21.90

u/l

2.43

850

3046

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

434

1232

1.88

29.23

1.2

1.1

—

(3007463) Buprenorphine [Presence] in Urine

5.00

29.18

7.4

7.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

434

1233

1.87

29.16

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

434

1236

1.87

28.95

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

429

1220

1.87

28.74

1.2

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

567

1757

1.72

28.72

1.4

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

428

1217

1.87

28.69

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

106

147

3.83

28.62

10.6

3.1

—

(3004616) Nuclear Ab [Presence] in Serum

533

1625

1.75

28.56

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

428

1219

1.87

28.55

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

304

767

2.11

28.32

1.1

—

(3000330) Specific gravity of Urine by Test strip

1451

5561

1.40

28.27

3.3

2.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1713

6752

1.36

28.14

1.8

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

130

212

3.26

28.08

3.3

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

130

212

3.26

28.08

3.3

2.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

116

175

3.52

28.02

1.5

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

548

1695

1.72

27.95

1.9

1.5

28.37

39.59

iu/ml

0.89

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

116

177

3.48

27.59

7.9

7.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

684

2253

1.62

27.58

1.2

—

(40768441) Liver Pathology biopsy report

343

917

1.99

27.47

1.6

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

321

839

2.04

27.33

2.4

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

437

1272

1.83

27.28

1.6

1.7

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

303

776

2.08

27.20

1.3

1.2

66.18

79.11

1.35

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

412

1178

1.86

27.19

1.3

1.2

1.89

1.86

mmol/l

0.19

379

1104

(3014148) Varicella zoster virus Ab [Titer] in Serum

856

2983

1.53

27.18

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

441

1291

1.82

27.05

2.2

2.3

73.06

73.55

0.22

430

1257

(21491868) Cryoglobulin [Mass/volume] in Serum

191

400

2.54

26.92

1.2

0.13

0.41

g/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

502

1531

1.75

26.90

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

396

1123

1.88

26.80

1.4

11.78

10.05

umol/l

5.70

372

1079

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

227

518

2.33

26.78

1.7

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

436

1276

1.82

26.77

2.2

2.3

12.07

13.89

3.32

428

1253

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

333

890

1.99

26.71

2.7

2.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

427

1246

1.82

26.47

2.6

3.3

4.37

8.24

nmol/l

0.41

410

1214

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

395

1124

1.87

26.47

1.3

1.2

197.00

184.57

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

395

1125

1.87

26.40

1.2

249.22

220.97

titre

0.20

206

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

294

754

2.07

26.32

1.1

—

(3045424) Erythrocytes [Presence] in Urine

684

2287

1.59

25.99

1.5

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2964

12718

1.25

25.92

1.7

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

136

3.79

25.87

1.5

1.2

13.66

13.99

g/l

0.10

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

250

605

2.20

25.83

1.1

95.14

95.37

0.04

125

266

(3026389) Candida sp identified in Specimen by Organism specific culture

670

2233

1.60

25.80

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

345

953

1.93

25.26

1.3

1.5

6.12

7.66

ug/l

0.87

308

859

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

240

577

2.21

25.20

1.2

1.3

94.42

84.47

u/l

0.49

215

504

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

317

853

1.98

25.00

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

236

567

2.21

24.83

1.2

1.3

23.10

17.69

u/l

0.60

210

487

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1410

5497

1.37

24.82

1.6

18.86

3.53

iu/ml

0.58

259

1111

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

251

619

2.16

24.81

1.2

112.91

107.89

0.84

227

552

(3034988) Calcium [Moles/volume] in Capillary blood

106

164

3.43

24.78

5.1

3.7

1.20

mmol/l

0.06

101

151

(3036782) Glucose [Moles/volume] in Pleural fluid

235

567

2.20

24.49

1.4

1.2

6.49

5.27

mmol/l

8.48

210

519

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

389

1132

1.83

24.37

1.2

1.1

1.05

1.06

ratio

0.52

138

403

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

235

569

2.20

24.29

1.2

0.30

0.29

g/l

1.64

191

450

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

243

597

2.16

24.26

1.7

158.91

130.39

4.09

231

557

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1251

4810

1.39

23.95

1.2

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

269

693

2.06

23.86

2.3

27.48

28.04

umol/l

0.36

261

668

(3003129) Base excess in Capillary blood by calculation

120

3.85

23.73

1.3

1.6

0.27

0.63

mmol/l

0.31

110

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

221

527

2.23

23.69

1.2

110.04

108.90

0.23

194

479

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

196

443

2.35

23.68

1.4

1.2

368.19

766.77

u/l

3.17

187

417

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

240

593

2.15

23.65

1.2

1.1

98.16

94.20

0.68

122

264

(3012441) Differential panel - Pleural fluid

230

560

2.18

23.48

1.5

1.4

—

(3023410) Appearance of Cerebral spinal fluid

528

1699

1.66

23.40

1.7

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

200

459

2.32

23.38

1.7

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

233

572

2.17

23.33

1.5

1.4

29855.16

50226.02

e6/l

0.89

129

352

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

241

600

2.14

23.32

1.7

1.6

7.52

5.25

u/l

1.50

207

478

(3034426) Prothrombin time (PT)

219

524

2.22

23.30

1.3

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

311

854

1.94

23.21

1.2

25.51

9.63

u/ml

0.65

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

201

465

2.30

23.09

1.7

1.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

155

3.39

22.79

4.4

3.5

1.21

1.20

mmol/l

0.31

140

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

246

624

2.10

22.73

2.2

3.0

1.51

1.16

ug/l

1.34

229

583

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

462

1446

1.70

22.70

1.4

1.3

5.76

6.04

umol/l

0.79

430

1353

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

216

520

2.21

22.67

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

124

227

2.90

22.41

2.7

1.6

750.83

3592.17

e6/l

0.72

133

(3017704) Immunofixation for Urine

152

312

2.59

22.37

1.4

2.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1790

7350

1.30

22.23

1.5

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

129

3.62

22.21

2.0

1.2

112.53

66.83

ng/l

2.91

129

(3019832) Treponema pallidum Ab [Presence] in Serum

6332

37900

0.87

22.02

1.8

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2179

9191

1.27

21.96

1.3

216.71

232.94

miu/ml

1.21

973

4682

(3047189) Immunofixation for 24 hour Urine

127

239

2.82

21.91

1.6

2.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

125

234

2.84

21.77

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

226

568

2.11

21.41

1.6

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

194

458

2.25

21.34

1.1

—

(4035726) Immunohistochemistry procedure

2607

11271

1.24

21.22

1.5

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

399

1223

1.74

21.15

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

279

763

1.94

21.13

2.8

2.5

12.73

10.21

1.51

269

732

(3000475) Leukocytes [#/volume] in Synovial fluid

693

2441

1.51

21.06

1.7

13070.40

11385.81

e6/l

0.36

504

1809

(3017354) Segmented neutrophils/100 leukocytes in Blood

337

986

1.82

20.85

3.0

3.1

55.49

53.19

1.14

301

832

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

184

429

2.28

20.84

3.6

2.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

396

1218

1.73

20.75

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

243

639

2.02

20.51

2.7

1.5

52.82

304.19

ug/l

1.01

230

607

(3042631) Mycobacterium sp identified in Specimen

349

1038

1.79

20.49

2.3

2.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

141

293

2.56

20.32

1.4

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

148

317

2.48

20.10

1.6

8.71

8.74

ug/l

0.03

148

317

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

163

366

2.37

20.07

2.6

2.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

370

1128

1.74

20.01

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1258

4986

1.35

20.00

1.3

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

+∞

19.99

7.8

0.0

45.23

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

391

1213

1.71

19.91

3.6

3.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.66

19.83

1.1

1.69

6.91

umol/24h

0.46

(3035880) pH of Pleural fluid

122

240

2.70

19.51

1.3

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

232

614

2.01

19.29

1.3

1.2

361.83

411.10

u/l

0.22

215

582

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

344

1041

1.76

19.11

1.1

1.03

1.08

u/l

0.54

140

475

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2622

11484

1.22

18.86

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

343

1042

1.75

18.81

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

176

422

2.22

18.75

2.1

1.4

22053.09

1167.18

u/ml

0.51

(3001186) Copper [Moles/volume] in Serum or Plasma

165

386

2.27

18.61

1.4

17.26

16.25

umol/l

1.12

146

343

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

382

1202

1.69

18.53

2.4

2.9

0.19

0.23

e9/l

2.46

320

1009

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.43

18.41

6.9

2.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

318

951

1.78

18.40

1.5

1.2

79.56

73.01

umol/l

1.25

318

951

(3033799) Differential panel - Peritoneal fluid

104

195

2.83

18.15

2.2

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

106

201

2.80

18.14

2.4

1.5

21110.55

13352.61

e6/l

0.17

(40768443) Skin Pathology biopsy report

1417

5801

1.30

18.03

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

152

348

2.32

18.00

2.5

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

386

1228

1.67

18.00

2.4

2.8

550.99

557.22

e6/l

0.05

319

1009

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

337

1037

1.73

17.72

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

219

586

1.99

17.72

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1420

5831

1.30

17.67

1.1

5.62

4.81

u/ml

0.31

190

950

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

213

567

2.00

17.49

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

270

780

1.84

17.48

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

860

3279

1.40

17.41

1.1

15.53

12.32

au/ml

0.39

278

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

240

668

1.91

17.39

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.89

17.15

15.5

2.9

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

181

2.84

17.10

1.3

1.5

68.17

84.71

ng/l

0.20

(3000060) B lymphocytes [#/volume] in Blood

227

624

1.93

17.06

2.7

2.4

168.91

277.69

e6/l

1.18

137

342

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1839

7838

1.25

16.99

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

280

826

1.80

16.99

1.0

1.1

96.54

93.81

0.74

228

654

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

186

2.80

16.78

1.4

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

188

486

2.05

16.71

1.2

1.1

19.51

18.40

u/l

0.15

178

437

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

4.72

16.67

5.9

7.7

68.85

62.32

0.50

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

145

338

2.28

16.55

1.4

1.3

129.18

129.57

nmol/l

0.01

113

257

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

188

488

2.05

16.54

1.2

1.1

75.08

73.10

u/l

0.17

178

443

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

151

361

2.22

16.28

1.2

1.1

73.96

77.04

0.19

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

150

358

2.22

16.24

1.2

1.1

81.94

92.15

1.05

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

388

3205

0.64

16.20

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

463

1585

1.55

16.13

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

174

443

2.09

16.11

2.0

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

174

443

2.09

16.11

2.0

1.7

—

(3044941) Cell count panel - Synovial fluid

466

1600

1.55

16.03

1.5

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

134

307

2.32

15.91

1.7

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

462

1586

1.55

15.91

1.4

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

181

471

2.04

15.85

1.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.77

15.84

1.3

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

310

963

1.71

15.83

1.6

34.56

38.51

0.89

194

635

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

259

763

1.80

15.83

1.9

4.25

2.62

mg/l

4.87

246

732

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

475

1643

1.54

15.82

1.4

1.5

—

(3044007) Cell count panel - Peritoneal fluid

187

2.72

15.73

2.4

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

316

990

1.70

15.67

1.2

1.3

55.48

40.40

u/ml

0.40

(3025468) Yersinia sp identified in Specimen by Organism specific culture

460

1584

1.55

15.64

1.4

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

429

1455

1.57

15.58

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

252

740

1.81

15.57

2.3

2.5

27.87

28.72

0.46

245

716

(3035947) Staphylolysin Ab [Units/volume] in Serum

203

555

1.94

15.55

1.1

4.14

3.70

iu/ml

0.25

(3038026) Centromere Ab [Units/volume] in Serum

321

1014

1.68

15.45

1.2

1.3

57.15

42.52

u/ml

0.32

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

156

387

2.14

15.43

1.3

106.98

102.89

0.74

150

360

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2376

10514

1.21

15.40

3.7

4.3

18.87

29.72

ug/l

0.86

1829

7934

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

103

211

2.59

15.39

1.8

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

465

1612

1.53

15.35

1.4

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

105

218

2.56

15.29

1.9

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

314

990

1.69

15.23

1.2

1.3

55.56

50.43

u/ml

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

464

1611

1.53

15.22

1.4

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

176

2.74

15.13

1.1

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

121

3.16

15.09

2.3

2.0

194.61

157.25

ug/g

0.96

106

(1761482) Bacteria [#/volume] in Urine by Culture

643

2392

1.43

15.01

3.8

2.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

307

968

1.69

14.90

1.1

1468.95

1478.41

miu/ml

0.05

307

968

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

192

523

1.95

14.88

1.6

1.4

12.72

11.08

u/l

1.92

185

510

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

113

248

2.42

14.75

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

113

248

2.42

14.75

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

113

248

2.42

14.75

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

113

248

2.42

14.75

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

145

356

2.16

14.73

1.3

12.00

18.42

u/l

3.00

133

337

(21494815) CD4 cells/100 lymphocytes in Specimen

438

1515

1.54

14.64

2.4

40.36

38.72

1.29

429

1494

(3014051) Protein [Presence] in Urine by Test strip

878

3465

1.35

14.47

2.5

2.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

291

912

1.70

14.46

1.6

1.7

23.30

25.94

umol/l

0.77

277

870

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

367

1224

1.59

14.35

1.2

1.3

1.74

2.96

u/ml

1.48

192

698

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

508

1822

1.48

14.34

3.2

37.95

385.37

u/ml

1.26

499

1801

(3009871) Measles virus Ab [Titer] in Serum

201

564

1.89

14.33

1.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

216

621

1.85

14.31

1.6

1.5

3.00

2.33

u/field

0.36

165

449

(3010144) Erythrocytes [#/volume] in Synovial fluid

291

917

1.69

14.18

1.4

84885.56

65687.86

e6/l

0.22

211

629

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

155

398

2.07

14.11

2.1

2.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

103

221

2.47

14.10

1.8

2.9

0.84

1.86

mmol/l

3.08

175

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

301

959

1.67

14.09

1.2

1.3

11.21

11.66

u/ml

0.03

(3021788) Differential panel - Synovial fluid

539

1965

1.46

14.03

1.6

1.5

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

157

2.77

13.92

1.8

1.6

112863.14

408668.39

nmol/l

0.74

127

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

145

365

2.11

13.89

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

165

2.70

13.63

1.4

1.2

57.07

58.22

0.09

138

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1078

4423

1.30

13.59

1.5

0.39

0.46

nmol/l

1.42

879

3613

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

137

341

2.13

13.51

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

168

454

1.97

13.38

1.2

22.96

10.99

1.14

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

180

499

1.92

13.33

1.4

19.60

20.51

u/ml

0.11

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

205

2.49

13.30

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

142

361

2.09

13.30

1.2

—

(3003694) ABO and Rh group [Type] in Blood

11462

56841

1.09

13.29

1.6

1.7

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

217

642

1.80

13.18

2.7

2.6

49.63

49.67

umol/l

0.01

196

580

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

6.46

12.98

2.8

2.4

2.18

2.41

ug/l

0.15

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1901

8371

1.21

12.98

1.9

1.4

4.69

3.22

mg/l

4.29

1510

5390

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

169

464

1.93

12.89

1.3

1.2

927.14

112.73

titre

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

186

528

1.87

12.87

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

164

447

1.95

12.77

1.3

1.2

68.33

87.54

titre

0.28

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

140

361

2.06

12.67

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

192

554

1.84

12.65

1.2

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

142

369

2.04

12.60

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

735

2891

1.35

12.45

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

195

569

1.82

12.41

1.6

2.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

377

1311

1.53

12.39

1.7

55.52

49.25

1.95

229

883

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.31

12.36

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

397

1397

1.51

12.36

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

114

2.98

12.32

1.3

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

440

1584

1.48

12.28

4.3

4.6

88.13

110.02

u/ml

0.31

127

559

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

238

740

1.71

12.26

1.5

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

195

572

1.81

12.22

1.6

2.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

302

1001

1.60

12.20

1.4

73.45

72.81

0.35

287

951

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

296

977

1.61

12.17

1.4

528.17

520.90

mu/l

0.05

281

927

(3017509) Phencyclidine [Presence] in Urine

126

318

2.10

12.07

2.7

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

748

2967

1.34

12.01

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

119

2.90

11.97

1.4

1.2

30.35

26.89

0.35

112

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

104

244

2.26

11.85

1.0

1.1

79.48

78.33

ug/l

0.10

213

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

187

547

1.82

11.84

1.3

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

132

2.77

11.80

1.2

1.1

6.80

2.10

pmol/l

1.05

(40761539) Cells [Type] in Urine sediment by Light microscopy

107

256

2.22

11.67

1.2

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

322

1096

1.56

11.67

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

124

2.82

11.65

1.5

1.3

27.34

26.25

g/l

0.16

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

139

370

1.99

11.61

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

152

418

1.93

11.60

2.6

3.1

27.95

28.40

umol/l

0.15

105

321

(3045142) Bone marrow Pathology biopsy report

328

1125

1.55

11.51

1.3

1.4

—

(3006270) Folate [Moles/volume] in Blood

295

989

1.58

11.41

1.1

401.33

395.00

nmol/l

0.20

273

907

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

9072

44786

1.09

11.28

1.8

1.7

—

(3020491) Glucose [Moles/volume] in Blood

320

1097

1.55

11.26

1.7

1.4

6.70

5.69

mmol/l

6.60

239

875

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

369

1306

1.50

11.23

2.2

1.8

24.53

26.37

mg/l

0.23

103

325

(3013293) Extractable nuclear Ab [Presence] in Serum

193

2.39

11.23

2.0

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

681

2694

1.35

11.17

1.8

5076.67

3063.82

titre

0.40

131

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

187

558

1.78

11.14

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

190

570

1.77

11.12

2.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

252

818

1.64

11.12

2.1

1.7

1.83

2.34

u/field

0.89

143

399

(3042951) Complement C1q Ab [Units/volume] in Serum

3.62

11.06

1.1

1.3

22.67

18.66

u/ml

0.20

(3035320) C reactive protein [Mass/volume] in Body fluid

298

1013

1.56

10.90

2.6

2.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

329

1144

1.53

10.89

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

102

247

2.19

10.85

1.0

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

3.32

10.75

1.5

1.4

8.23

10.11

pmol/l

0.31

(3051387) C reactive protein [Mass/volume] in Capillary blood

732

2945

1.32

10.74

3.7

2.5

20.85

26.24

mg/l

4.51

458

1778

(3018133) Calcium [Moles/volume] in Urine

122

319

2.03

10.73

2.3

2.6

2.89

2.75

mmol/l

0.23

111

297

(3001893) Eosinophils/100 leukocytes in Pleural fluid

134

2.65

10.62

1.4

1.2

2.59

4.99

1.05

117

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

256

846

1.61

10.55

4.6

4.7

—

(21494434) Karyotype in Bone marrow

245

804

1.62

10.39

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

172

512

1.78

10.36

1.5

5.59

4.22

0.43

124

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.17

10.12

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

4816

28066

0.90

10.09

1.3

—

(3028433) Virus identified in Specimen by Culture

153

447

1.82

9.82

1.1

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

346

1246

1.48

9.76

2.4

2.9

781.95

745.20

e6/l

0.30

340

1222

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

202

643

1.67

9.67

1.3

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

139

2.52

9.53

1.3

1.2

52.15

45.12

mg/l

0.58

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

394

1466

1.43

9.40

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

155

462

1.78

9.35

1.7

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

155

462

1.78

9.35

1.7

2.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

108

286

2.00

9.26

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

111

297

1.98

9.25

2.5

2.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

134

383

1.86

9.24

1.6

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

184

579

1.69

9.22

1.1

157.50

254.54

ng/l

0.49

123

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

880

3705

1.26

9.21

3.2

3.9

4610.43

2376.47

u/ml

0.28

751

3185

(3004716) Salmonella sp identified in Stool by Organism specific culture

2513

11667

1.15

9.19

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

28562

147936

1.07

9.09

3.9

3.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

688

2814

1.30

9.05

1.4

1.5

7.16

6.35

mmol/l

12.34

635

2531

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

500

1955

1.36

8.95

1.3

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

187

2.24

8.95

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

147

439

1.78

8.85

1.3

1.4

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.94

8.79

1.2

1.3

0.92

1.00

umol/24h

0.05

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

147

440

1.77

8.78

1.3

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

155

473

1.74

8.69

1.7

2.2

—

(40757373) Influenza virus identified in Isolate

187

2.21

8.60

1.8

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

187

2.21

8.60

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

257

899

1.52

8.41

1.7

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

783

3290

1.27

8.38

1.2

—

(3024263) Appearance of Synovial fluid

166

523

1.68

8.33

1.5

1.6

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

5.30

8.29

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

15.91

8.15

1.4

1.0

40.46

30.76

mu/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

479

1890

1.35

8.14

3.6

3.8

862.27

523.27

u/ml

0.27

449

1715

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

100

271

1.96

8.11

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

101

275

1.95

8.09

1.4

47.31

48.47

0.11

241

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

5.60

7.87

1.2

181.80

91.65

ug/l

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

4.39

7.85

1.5

1.3

119.00

138.88

nmol/l

0.22

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.39

7.85

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.50

7.71

1.5

1.3

572.00

522.73

nmol/l

0.14

(3022229) Phosphate [Moles/volume] in Urine

148

2.29

7.70

2.5

2.8

22.10

21.63

mmol/l

0.06

136

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

250

890

1.49

7.59

6.4

7.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

156

2.24

7.57

1.2

1.1

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

5.05

7.55

4.1

3.0

1080.60

2654.63

umol/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

294

1.88

7.51

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1916

8859

1.15

7.47

2.5

2.8

38.09

41.21

u/ml

0.32

1850

8591

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.33

7.43

1.3

30.40

694.58

u/l

0.62

(3001964) Herpes simplex virus Ag [Presence] in Specimen

147

466

1.67

7.28

1.6

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

489

1970

1.32

7.28

1.4

1.5

8.52

6.80

mmol/l

15.73

478

1944

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

238

1.96

7.23

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.82

7.22

1.1

—

mmol/l

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2749

16224

0.89

7.19

1.4

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

131

404

1.72

7.17

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

164

2.17

7.11

2.6

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

7690

38341

1.08

7.11

1.6

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

207

2.02

7.08

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

102

2.50

6.92

1.1

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

159

522

1.62

6.92

1.3

1.5

6.18

5.76

nmol/l

0.62

152

500

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.79

6.92

1.2

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.22

6.90

1.1

25.11

26.68

u/l

0.08

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.57

6.85

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

167

2.13

6.83

1.1

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.65

6.80

1.2

1.77

2.27

mmol/l

1.01

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.69

6.63

1.2

1.3

0.99

1.95

mmol/l

0.77

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.49

6.62

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

215

766

1.49

6.57

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.69

6.48

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

243

890

1.45

6.48

2.7

2.9

44.68

40.98

2.25

152

445

(3038177) Helicobacter pylori Ab [Presence] in Serum

755

3260

1.23

6.47

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

171

2.08

6.46

1.6

1.2

—

(3001556) Androgen free Index in Serum or Plasma

111

337

1.75

6.46

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

124

391

1.68

6.33

1.2

1.1

—

(3014891) Appearance of Pleural fluid

2.92

6.32

1.4

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

202

1.97

6.29

1.8

2.0

29.08

31.60

pmol/l

0.12

170

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

104

924

0.60

6.28

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

101

2.42

6.25

2.2

2.1

—

(3013466) aPTT in Blood by Coagulation assay

111

2.34

6.24

1.1

35.14

36.77

1.67

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

4.38

6.23

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.87

6.16

1.3

1.5

—

13.37

—

(3008536) Aspergillus sp Ab [Presence] in Serum

245

1.86

6.15

2.5

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

7.07

6.15

3.8

5.6

2.08

2.58

mg/l

—

(3032057) Clostridioides difficile [Presence] in Stool

175

2.03

6.11

2.0

1.9

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

162

552

1.56

6.11

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.00

6.03

1.7

1.9

37.43

45.60

umol/l

1.23

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

141

2.14

5.97

1.1

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

131

2.19

5.92

1.9

7.77

6.61

mmol/l

0.70

(3000285) Sodium [Moles/volume] in Blood

2.43

5.92

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.73

5.85

1.1

87.17

55.40

u/l

0.38

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

122

2.22

5.79

2.8

3.1

1.22

1.55

mg/l

0.35

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

184

1.96

5.68

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

118

989

0.63

5.62

3.4

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

118

989

0.63

5.62

6.8

6.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

105

328

1.70

5.60

3.6

3.9

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

3.05

5.57

1.7

1.9

182.05

183.32

ng/l

0.03

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

167

2.00

5.57

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.37

5.53

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4060

23186

0.92

5.43

1.7

1.5

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.92

5.23

1.3

1.4

73.05

73.57

0.03

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.85

5.23

1.5

1.8

—

(3019174) dRVVT (LA screen)

153

2.01

5.22

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

143

2.04

5.14

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

165

1.96

5.14

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.42

5.12

1.3

1.4

0.98

2.56

ml/s/173m2

1.26

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

309

1.68

5.10

1.7

1.8

43.65

36.44

u/l

0.15

271

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

4.24

5.09

1.2

2.94

2.85

0.03

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.70

5.09

1.0

9.25

2.71

iu/ml

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.80

5.07

1.1

0.20

0.21

g/l

0.21

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

196

1.87

5.06

1.7

1.41

1.77

mg/l

0.25

128

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

134

2.06

4.99

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

316

1270

1.32

4.95

1.1

9.48

7.49

iu/ml

0.63

353

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

191

1.86

4.87

1.6

1.7

0.64

1.01

mg/l

0.60

133

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

191

1.86

4.87

1.6

1.7

1.88

1.09

mg/l

0.49

117

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

191

1.86

4.87

1.6

1.7

2.03

3.27

mg/l

0.95

136

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

191

1.86

4.87

1.6

1.7

4.78

4.20

mg/l

0.18

124

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

191

1.86

4.87

1.6

1.7

1.32

2.72

mg/l

1.47

129

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

191

1.86

4.87

1.6

1.7

1.11

2.71

mg/l

2.30

142

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

191

1.86

4.87

1.6

1.7

2.76

2.84

mg/l

0.03

142

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

191

1.86

4.87

1.6

1.7

1.97

1.61

mg/l

0.25

141

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

191

1.86

4.87

1.6

1.7

1.59

1.98

mg/l

0.26

126

(40765089) Chromosome analysis panel - Blood by G-banded

168

1271

0.70

4.83

1.0

—

(40765096) Chromosome analysis panel by Banding

298

1.67

4.82

1.1

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

498

3247

0.81

4.81

1.5

1.6

8.04

7.40

mmol/l

8.33

477

3122

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

219

1.79

4.80

1.3

1.2

188.85

54.32

mg/l

0.71

147

(3003740) Influenza virus B Ag [Presence] in Specimen

914

4149

1.17

4.70

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

11051

56374

1.05

4.66

2.2

2.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

156

1187

0.70

4.66

2.8

3.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.25

4.64

1.0

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

131

2.02

4.62

1.4

1.3

27.39

21.60

0.60

107

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

142

1.98

4.62

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

222

1.77

4.61

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

912

4150

1.17

4.56

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

7820

39539

1.06

4.55

2.3

2.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.37

4.55

2.2

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

4191

20767

1.08

4.50

2.0

1.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

329

1350

1.29

4.48

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.60

4.48

2.1

2.5

3.30

2.24

mu/l

0.30

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.42

4.48

1.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

155

1.92

4.47

2.4

2.8

54.41

53.51

pmol/l

0.03

124

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

3.98

4.45

1.6

1.4

240.40

139.95

umol/l

0.67

(3002619) Bacteria identified in Specimen by Culture

263

1.67

4.31

1.2

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.77

4.30

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1632

7759

1.12

4.29

1.6

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

453

1946

1.24

4.24

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

115

397

1.54

4.24

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

376

1582

1.26

4.23

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.56

4.20

1.0

0.45

0.77

u/ml

0.32

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.24

4.15

1.1

1.0

17.94

10.58

u/l

0.44

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

175

1.82

4.13

1.7

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.47

4.10

1.6

1.3

8.21

10.62

0.26

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

5209

26097

1.07

4.09

2.1

2.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

161

1.84

4.04

1.3

46.00

61.71

1.43

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

150

1.87

4.01

3.2

3.9

44.52

44.03

umol/l

0.05

124

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

+∞

4.00

2.8

0.0

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.14

3.90

2.4

4.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

324

1354

1.27

3.89

1.6

1.3

0.95

g/l

0.13

324

1346

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

123

440

1.48

3.88

1.2

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

215

1.70

3.85

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

123

441

1.48

3.85

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

128

463

1.47

3.83

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

153

1.84

3.80

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

169

1.79

3.76

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

127

1.92

3.76

1.0

1.1

0.47

15.97

u/ml

0.50

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.26

3.72

2.6

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.65

3.69

1.0

0.17

0.01

u/ml

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.65

3.69

1.2

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

122

441

1.47

3.68

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

911

5507

0.87

3.68

1.3

3.21

3.63

ug/l

1.16

846

5113

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

179

1.75

3.63

1.2

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

144

1.84

3.63

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.31

3.57

1.1

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

2.10

3.52

6.2

3.9

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

255

1.60

3.46

1.4

1.3

33.29

45.10

1.89

181

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.03

3.44

2.9

3.1

25.47

802.91

pmol/l

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

2.18

3.41

1.4

1.5

18.57

13.81

0.31

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

5.30

3.40

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

224

1.63

3.36

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

267

1113

1.27

3.34

1.5

5.53

5.11

mmol/l

4.94

255

1061

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.44

3.33

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1184

5618

1.12

3.31

1.1

2.10

2.49

u/ml

0.63

601

2982

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

1.85

3.28

1.1

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

132

497

1.41

3.26

2.4

3.4

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.36

3.24

1.0

0.15

0.08

u/ml

0.29

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

108

1.91

3.21

2.4

4.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.39

3.21

1.9

1.4

0.00

u/l

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

4.82

3.18

1.2

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

192

1.66

3.11

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

229

1.60

3.11

1.4

1.6

0.43

0.40

ug/l

0.20

149

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

5.30

3.11

2.9

4.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

213

1.62

3.09

1.0

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.58

3.08

2.4

1.3

18.77

32.06

0.62

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

8544

43707

1.05

3.07

2.4

2.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.02

3.05

3.7

5.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

154

0.34

3.05

1.0

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.95

3.03

1.5

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

122

1.83

3.02

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

138

1.77

3.00

1.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

891

4185

1.13

2.99

1.5

1.4

117.21

88.05

pmol/l

0.78

869

4072

(1617658) Protocol used for examination of sentinel lymph nodes

169

1175

0.76

2.98

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

308

1.50

2.98

1.2

1.3

—

(3024316) Viscosity of Plasma

2.30

2.98

1.0

1.9

1.29

1.88

mpas

2.51

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.47

2.98

1.1

1.0

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

2.52

2.94

1.0

0.02

0.04

u/ml

0.49

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.52

2.94

1.3

1.5

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.33

2.94

2.4

1.4

53.79

55.22

0.05

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.23

2.92

1.0

0.02

0.12

u/ml

1.16

(3018738) Hemoglobin F/Hemoglobin.total in Blood

204

1.61

2.92

3.6

2.5

5.89

5.65

0.03

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

314

1.49

2.92

1.1

1.0

0.03

0.13

u/ml

0.84

186

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.91

2.90

1.6

1.3

317.14

307.33

umol/24h

0.10

(3007456) Orange IgE Ab [Units/volume] in Serum

2.26

2.87

1.0

0.04

0.31

u/ml

0.71

(3036071) Salmonella sp Ab [Titer] in Serum

167

671

1.32

2.82

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

133

1.75

2.82

1.1

1.2

55.76

365.45

ug/l

1.39

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.02

2.80

1.1

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

166

1.66

2.76

1.3

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

235

991

1.26

2.75

1.4

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

216

1.57

2.74

2.9

3.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

216

903

1.27

2.72

1.1

7.89

13.17

u/ml

1.48

172

(3012989) Citrate [Moles/time] in 24 hour Urine

2.74

2.71

1.3

1.2

2.56

1.95

mmol/24h

0.43

(3034614) HLA Ag [Interpretation]

2.40

2.70

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

333

1.45

2.69

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.01

2.66

1.6

1.3

—

(3023383) Lactate [Moles/volume] in Pleural fluid

172

1.63

2.66

1.3

1.2

3.72

4.18

mmol/l

0.34

156

(3026470) Cobalt [Mass/volume] in Blood

113

433

1.38

2.61

2.0

3.34

3.30

ug/l

0.02

101

396

(3009992) Blasts/100 cells in Bone marrow

4.71

2.60

1.9

9.25

11.89

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.07

2.58

1.3

0.67

1.88

0.85

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.03

2.54

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.03

2.54

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.03

2.54

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.03

2.54

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.03

2.54

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.03

2.54

2.0

—

(3015183) Erythrocyte sedimentation rate

275

1193

1.22

2.53

1.2

—

(3006598) pH of Arterial cord blood

198

0.48

2.48

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

256

1.49

2.48

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.92

2.48

1.3

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

201

1.56

2.46

1.1

1.4

33.64

43.36

mg/l

0.92

172

(3003888) Timothy IgE Ab [Units/volume] in Serum

1060

5093

1.11

2.46

1.1

5.71

6.80

u/ml

1.24

566

2856

(3025577) Chromium [Mass/volume] in Blood

110

425

1.37

2.44

2.0

3.01

2.41

ug/l

0.39

365

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.56

2.43

1.1

1.2

1.13

1.11

u/field

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

240

1.50

2.43

2.0

1.6

1.80

1.69

mg/l

0.20

201

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1006

4827

1.11

2.41

1.1

1.00

1.25

u/ml

0.64

434

2248

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

132

1.69

2.40

2.5

1.8

0.83

0.70

u/field

0.29

132

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.97

2.38

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

729

3438

1.13

2.38

1.1

2.91

3.03

u/ml

0.10

361

1829

(3007916) DNA double strand Ab [Titer] in Serum

157

1.62

2.37

1.7

1.2

365.00

111.26

titre

—

(3006567) Chloride [Moles/time] in 24 hour Urine

3.67

2.36

1.1

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

5861

29917

1.04

2.32

1.5

1.4

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

191

0.50

2.26

1.0

1.1

4.59

3.88

kpa

0.19

159

(3005011) Chlamydia sp Ab [Titer] in Serum

289

1.43

2.23

1.6

1.5

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

3.41

2.21

1.1

1.2

147.11

287.64

nmol/l

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.83

2.18

1.4

41.09

28.30

0.77

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

166

1.57

2.14

2.2

1.7

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.29

2.11

1.3

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.79

2.11

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

206

1.49

2.07

1.0

1.1

0.16

1.07

u/ml

4.56

134

(3005082) Progesterone [Moles/volume] in Serum or Plasma

360

2216

0.86

2.06

1.3

1.4

25.79

32.73

nmol/l

5.78

319

2071

(3032352) Blasts [#/volume] in Cerebral spinal fluid

172

1.54

2.06

3.5

3.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

727

3463

1.11

2.05

2.9

1.9

13.14

13.03

2.35

713

3424

(3007700) Barley IgE Ab [Units/volume] in Serum

114

1.67

2.05

1.0

1.1

0.55

13.11

u/ml

0.50

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

271

1203

1.20

2.04

1.4

1.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

156

1.56

2.02

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.99

2.01

1.9

2.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

280

1752

0.85

1.98

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.91

1.97

1.6

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

128

1.62

1.96

1.1

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

293

1.39

1.94

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.77

1.92

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

946

4585

1.10

1.92

1.6

1.5

—

(3045177) Copper [Moles/volume] in Urine

2.65

1.91

1.0

0.14

0.33

umol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

174

745

1.24

1.90

1.2

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

5.30

1.90

1.0

15.60

14.40

umol/l

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

112

455

1.31

1.87

1.4

1.6

0.19

0.24

nmol/l

0.90

337

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

242

1074

1.20

1.86

2.0

2.2

19.70

25.06

ug/l

1.64

237

1061

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.45

1.82

2.3

2.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

170

1.50

1.77

1.0

0.24

0.98

u/ml

0.68

104

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

202

0.58

1.77

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

124

1.58

1.74

1.1

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

852

4133

1.09

1.73

1.1

4.82

4.67

u/ml

0.07

414

2076

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

159

1.50

1.69

1.4

1.3

16.24

16.06

nmol/l

0.03

(3009015) Lactate [Moles/volume] in Synovial fluid

1.69

1.68

1.5

1.2

5.44

5.75

mmol/l

0.12

(3003721) Smooth muscle Ab [Units/volume] in Serum

134

1.54

1.67

1.2

1.1

2.72

3.01

u/ml

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

143

1.52

1.64

1.1

0.77

2.32

u/ml

1.35

104

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.02

1.62

1.3

1.2

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.67

1.62

1.1

22.50

19.52

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.68

1.62

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.27

1.59

1.1

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

145

1.50

1.56

1.1

1.5

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.65

1.54

1.3

1.1

1.11

1.51

mg/l

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

134

575

1.24

1.51

1.2

1.1

54.60

60.61

u/ml

0.45

134

559

(3001729) Color of Synovial fluid

1.70

1.49

2.0

1.7

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

132

571

1.23

1.40

1.0

1.1

6.24

1.76

u/ml

0.44

110

506

(3010726) Horse dander IgE Ab [Units/volume] in Serum

999

4934

1.07

1.38

1.1

1.97

2.47

u/ml

0.94

509

2587

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.74

1.36

1.1

0.03

0.75

mg/l

0.51

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

319

1.30

1.33

1.0

0.10

0.21

u/ml

0.57

192

(3034092) Cytoplasmic Ig cells/100 cells in Blood

218

1.36

1.33

9.7

3.3

—

(40768795) Lymph node Pathology biopsy report

296

1381

1.14

1.31

1.3

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

251

1.33

1.30

1.3

38.46

40.83

g/l

0.70

142

(3032868) Hemoglobin electrophoresis panel in Blood

206

1.36

1.28

1.5

1.6

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

2.21

1.27

1.0

—

(36303858) Crystals [Presence] in Urine

2.36

1.26

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.71

1.24

1.2

1.00

1.13

u/field

1.24

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.71

1.24

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

786

3869

1.08

1.23

1.1

7.05

6.01

u/ml

0.37

345

1727

(3003157) Bacteria [#/volume] in Mother's milk

0.50

1.20

3.8

6.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

120

525

1.21

1.19

1.3

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

415

1.24

1.19

1.1

—

(3003577) Lead [Moles/volume] in Blood

180

0.65

1.18

1.2

1.5

0.17

0.25

umol/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

327

1550

1.12

1.15

1.7

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

182

830

1.16

1.14

2.0

2.2

8.98

9.92

mg/l

1.33

146

666

(3045683) HLA typing for celiac disease panel - Blood or Tissue

308

1457

1.12

1.13

1.0

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

1.93

1.12

1.1

1.0

0.05

0.19

u/ml

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.93

1.12

1.3

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

2.65

1.12

5.2

7.9

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.65

1.12

1.0

1.1

—

(3013931) Oligosaccharides [Presence] in Urine

2.65

1.12

1.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.81

1.11

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

410

2384

0.91

1.07

3.6

29.23

36.90

u/ml

0.85

397

2301

(40768793) Breast Pathology biopsy report

645

3678

0.93

1.06

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

298

1.26

1.05

1.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.55

1.05

1.0

0.06

0.19

u/ml

0.55

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.87

1.04

1.2

1.3

1.86

1.32

u/field

—

(3041672) Baker's yeast Ab [Presence] in Serum

141

1.39

1.04

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.99

1.04

1.4

1.3

—

(3048879) Bone marrow aspiration report

233

1.30

1.03

1.8

2.5

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

1.03

0.0

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

187

1.33

1.03

1.0

0.11

2.43

u/ml

1.99

147

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

187

1.33

1.03

1.0

15.85

22.35

u/ml

0.34

154

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

165

1.35

1.00

1.0

0.06

0.70

u/ml

2.18

154

(4281824) Cell count and differential, peritoneal fluid

299

1425

1.11

1.00

1.2

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

2.06

0.99

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

135

610

1.17

0.99

1.0

41.40

41.43

ng/l

0.00

469

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

133

603

1.17

0.95

1.0

277.48

331.27

ng/l

1.14

471

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

265

1.26

0.94

1.3

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

269

1280

1.11

0.94

1.2

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.02

0.92

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

124

766

0.86

0.91

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

287

1374

1.11

0.91

1.4

—

(3020650) Glucose [Presence] in Urine

110

495

1.18

0.87

1.5

1.4

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.62

0.86

1.1

1.0

0.09

1.65

u/ml

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

255

1.25

0.85

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

133

610

1.16

0.84

1.0

808.64

761.90

ng/l

0.53

457

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.55

0.83

1.1

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.58

0.82

1.1

1.6

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

290

1.22

0.81

1.0

1.1

0.02

0.50

u/ml

2.70

164

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

169

792

1.13

0.80

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

2.41

0.80

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.41

0.80

1.2

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

384

1.19

0.77

2.0

2.8

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

293

1.21

0.75

1.3

2.0

1.84

4.16

ug/l

0.79

184

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.86

0.74

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

149

698

1.13

0.73

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

178

844

1.12

0.72

1.1

4.05

21.74

u/ml

0.94

103

537

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

141

660

1.13

0.71

1.9

1.8

139.39

148.54

au/ml

0.07

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

671

3371

1.06

0.68

1.0

1.1

0.54

0.45

u/ml

0.16

190

886

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.57

0.68

15.2

9.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.37

0.67

4.8

2.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.61

0.67

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.35

0.66

1.2

1.1

—

(40763590) HLA-DQ beta [Type]

1.45

0.65

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.45

0.65

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

1.62

0.65

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.70

0.64

1.1

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.66

0.64

1.0

—

(4212803) Bone marrow aspirate examination

1.42

0.63

1.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

201

975

1.09

0.57

2.6

2.9

143.65

149.08

au/ml

0.05

139

(40759632) Porphyrins [Mass/mass] in Stool

1.67

0.57

1.2

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.54

0.56

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

208

1013

1.09

0.55

1.9

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

319

1581

1.07

0.54

1.0

1.1

0.46

1.18

u/ml

1.12

436

(40760409) HLA-A [Type] by High resolution

1.39

0.51

1.0

—

(40760410) HLA-B [Type] by High resolution

1.39

0.51

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.49

0.49

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

264

1.16

0.48

2.1

2.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

161

782

1.09

0.48

1.3

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

324

1.15

0.47

1.0

1.1

0.01

2.34

u/ml

1.24

167

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.45

0.47

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

185

1057

0.93

0.44

1.3

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

120

1.24

0.44

1.8

1.4

—

(40758358) Immune stain study

0.71

0.43

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.47

0.43

1.0

1.1

—

(3013762) Body weight Measured

0.73

0.42

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.56

0.42

1.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.66

0.41

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.29

0.41

1.0

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

226

0.84

0.41

1.2

1.1

21.51

19.65

mmol/l

1.89

206

(3013862) HLA-DP [Type]

1.33

0.41

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.42

0.40

4.4

5.8

0.27

0.18

mmol/l

0.45

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

342

1721

1.05

0.40

1.4

1.3

184.34

207.93

pmol/l

0.35

342

1721

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.47

0.40

1.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.68

0.38

1.1

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

352

1777

1.05

0.38

1.0

1.1

0.93

3.11

u/ml

2.72

131

628

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.74

0.38

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.51

0.37

1.2

1.0

713.33

1961.90

titre

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.51

0.37

1.2

1.0

—

(3022475) Manganese [Moles/volume] in Blood

123

1.21

0.36

1.4

1.3

—

(3006462) Nitrate [Presence] in Urine

146

718

1.08

0.36

2.4

2.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

214

1068

1.06

0.35

3.2

3.5

7.57

8.52

mg/l

1.45

170

862

(44786800) Granulocytes/100 leukocytes in Body fluid

1.30

0.35

1.4

1.2

26.90

32.20

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

379

0.89

0.35

1.2

1.3

—

(3025130) Human papilloma virus identified in Specimen

709

3641

1.03

0.35

1.8

—

(3049233) Organic acids panel - Urine

1.33

0.34

1.1

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.32

0.34

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

927

4788

1.03

0.32

2.6

2.3

6.17

5.76

umol/l

0.35

674

3540

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

173

862

1.06

0.32

1.0

1.1

9.61

13.98

u/ml

1.86

111

517

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.23

0.28

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

341

1738

1.04

0.28

1.1

2.84

6.21

u/ml

0.70

493

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

215

1196

0.95

0.27

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

324

1.10

0.27

1.0

1.1

0.02

0.99

u/ml

2.00

175

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.33

0.26

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

418

1.08

0.24

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

129

1.15

0.24

2.1

2.4

2.85

4.40

ug/l

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

102

0.83

0.24

1.1

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.22

0.24

4.9

6.5

—

(40762887) Creatinine [Moles/volume] in Blood

1.32

0.24

1.2

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

210

1.11

0.23

1.0

1.1

3.82

10.85

u/ml

3.52

146

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

158

880

0.95

0.23

6.8

405.67

4300.76

u/ml

0.66

202

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3025311) HLA-B [Type]

0.00

0.22

0.0

1.0

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.22

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

378

2064

0.97

0.21

1.8

1.9

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.21

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.19

0.21

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

780

4053

1.02

0.20

1.3

—

(3022670) pH of Venous cord blood

0.83

0.20

1.1

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

239

0.91

0.20

1.3

1.1

6.60

mmol/l

0.00

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

246

1346

0.97

0.17

1.2

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.76

0.17

1.0

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.76

0.17

1.0

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

231

0.92

0.17

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

868

4534

1.01

0.15

1.9

1.7

—

(3032641) Amino acids panel - Urine

1.11

0.15

1.4

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.14

0.14

1.1

1.0

0.75

0.47

u/ml

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

249

1.06

0.13

1.0

0.09

1.60

u/ml

2.27

169

(3027974) Hepatitis B virus e Ag [Presence] in Serum

126

1.09

0.12

1.9

1.5

—

(3018291) Platelet Ab [Presence] in Serum

1.10

0.10

1.0

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

343

0.96

0.09

1.0

1.1

0.15

3.62

u/ml

4.08

272

(3039443) Prostate specific Ag panel - Serum or Plasma

528

2833

0.99

0.09

1.6

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

284

1.05

0.09

2.5

3.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

417

0.97

0.08

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

196

1.05

0.08

1.1

21.75

35.42

u/ml

0.74

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

196

1.05

0.08

1.1

29.71

23.14

u/ml

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.03

0.07

1.1

1.3

224.04

240.10

nmol/l

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

351

0.97

0.07

1.0

1.1

0.05

5.20

u/ml

2.82

276

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.12

0.07

1.1

—

(3008607) Semen analysis panel

280

0.97

0.06

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

1.09

0.05

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.07

0.05

1.0

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.93

0.05

1.0

0.16

0.34

u/ml

—

(3016135) IgD [Mass/volume] in Serum

1.10

0.04

1.1

1.4

37.15

139.35

mg/l

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.10

0.04

1.8

1.9

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

105

548

1.02

0.03

3.0

2.1

138.46

105.35

ng/l

0.42

358

(40768800) Prostate Pathology biopsy report

336

1792

0.99

0.03

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

113

592

1.01

0.02

1.1

1.60

9.40

u/ml

3.05

429

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

233

1.02

0.02

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1767

9350

1.00

0.02

2.0

1.9

—

(40758292) HTLV I+II Ab panel - Serum

349

0.99

0.01

1.3

1.4

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.96

0.01

1.0

0.26

1.21

u/ml

—

(3011325) HIV 1+2 Ab [Presence] in Serum

107

0.99

0.00

1.2

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

103

1.03

0.00

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

193

1.02

0.00

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

121

643

1.00

0.00

1.6

2.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.91

0.00

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.88

-0.00

1.0

1.3

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.94

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint RX_ANTIHYP and mortality.

Females

Parameter	HR [95% CI]	p-value
RX_ANTIHYP	0.891 [0.84, 0.95]	< 0.001
Birth year	0.998 [0.99, 1.0]	0.496

During the follow-up period (1.1.1998 — 31.12.2019), 143742 out of 808782 females with RX_ANTIHYP died.

Males

Parameter	HR [95% CI]	p-value
RX_ANTIHYP	0.995 [0.93, 1.06]	0.886
Birth year	0.988 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 148263 out of 757662 males with RX_ANTIHYP died.

Mortality risk

Mortality risk for people of age

years, who have RX_ANTIHYP.

N-year risk	Females	Males
1	0.071%	0.14%
5	0.42%	0.87%
10	1.084%	2.296%
15	2.231%	4.492%
20	4.044%	7.782%

Relationships between endpoints

↥

Index endpoint: RX_ANTIHYP – Antihypertensive medication - note that there are other indications

GWS hits: 325

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Antihypertensive medication - note that there are other indications

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints